Toolkit for implementing programs for people who use drugs (PWUD) by Kroeger, Karen. et al.

   
 
 
 
 
 
 
 
 
 
  
  
     
 
 
 
 
 
 
This toolkit was prepared by:
Karen Kroeger, PhD 
Shama Patel, MPH 
Hrishikesh Belani, MPH 
Sasha Mital, MPH 
Centers for Disease Control and Prevention,  
Global AIDS Program, Prevention Branch, Atlanta, GA, USA 
Richard Needle, PhD, MPH 
Office of the Global AIDS Coordinator,  
Washington, DC 
Acknowledgements
We would like to acknowledge the contributions of PEPFAR Most at Risk Technical
Working Group members who provided substantial input on sections of the document, in 
particular Tom Kresina, Karina Rapposelli, and Abu Abdul-Quadar. We would also like to 
acknowledge Colleen Kapsimalis for her assistance in finalizing the document.
For information about this toolkit, contact: 
Karen Kroeger, PhD 
404-639-4488 
kkroeger@cdc.gov 
Karina Rapposelli, MPH 
404-639-0926 
krapposelli@cdc.gov 
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 2
   
 
 
     
   
   
   
     
   
      
   
   
    
    
   
   
   
   
   
   
   
    
   
   
      
   
   
   
   
   
   
   
   
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 3
TABLE OF CONTENTS
CHAPTER 1: ABOUT THIS TOOLKIT ...........................................................................................6
 
CHAPTER 2: BACKGROUND AND OVERVIEW OF DRUG USE AND HIV ..................................7
 
Drug Use and HIV......................................................................................................................7
 
HIV Risk among People who Use Drugs....................................................................................8
 
CHAPTER 3: ASSESSING THE LOCAL DRUG USE CONTEXT ..................................................9
 
What should be assessed? ........................................................................................................9
 
Considerations for Assessing the HIV Prevention Needs of People who Use Drugs ................12
 
CHAPTER 4: PLANNING COMPREHENSIVE HIV PREVENTION PROGRAMS FOR PEOPLE 
WHO USE DRUGS......................................................................................................................13
 
Program Development .............................................................................................................13
 
HIV/AIDS Prevention Program for People who use Drugs .......................................................13
 
Principles in Service Delivery to People who Use Drugs..........................................................13
 
CHAPTER 5: IMPLEMENTING HIV INTERVENTIONS AMONG PEOPLE WHO USE DRUGS ..16
 
5.1 Community Outreach .........................................................................................................16
 
5.2 Risk Reduction Counseling and Behavior Change Interventions ........................................17
 
Risk Reduction Counseling ..................................................................................................17
 
Behavior change interventions .............................................................................................18
 
5.3 HIV Testing and Counseling...............................................................................................19
 
Types of HTC.......................................................................................................................20
 
Settings for HTC ..................................................................................................................20
 
HTC and People who use Drugs..........................................................................................20
 
5.4 Condom Distribution and Promotion...................................................................................22
 
5.5 Access to and Safe Disposal of Injection Equipment..........................................................22
 
5.6 STI Screening and Treatment ............................................................................................23
 
5.7 HIV Care and Treatment ....................................................................................................24
 
5.8 Treatment for Drug Use and Dependence..........................................................................25
 
Assessment of Drug Use and Drug Dependence .................................................................25
 
Drug Use and Dependence Treatment.................................................................................26
 
5.9 Prevention, Diagnosis and Treatment of Tuberculosis .......................................................28
 
5.10 Vaccination, Diagnosis, and Treatment of Viral Hepatitis .................................................29
 
CHAPTER 6: IMPLEMENTING HIV INTERVENTIONS AMONG INCARCERATED PEOPLE 

WHO USE DRUGS......................................................................................................................30
 
   
   
   
   
   
   
  
   
   
     
    
   
 
 
 
 
CHAPTER 7: MONITORING AND EVALUATING HIV INTERVENTIONS AMONG PEOPLE WHO
 
USE DRUGS ...............................................................................................................................32
 
Process monitoring and evaluation ..........................................................................................32
 
Uptake and Coverage ..............................................................................................................32
 
Outcome Evaluation.................................................................................................................33
 
CHAPTER 8: ADVOCACY AND POLICY FOR HIV INTERVENTIONS AMONG PEOPLE WHO
 
USE DRUGS ...............................................................................................................................36
 
APPENDICES .............................................................................................................................37
 
APPENDIX 1: ANNOTATED LIST OF TOOLS.........................................................................38
 
APPENDIX 2: ADDITIONAL WEB RESOURCES ....................................................................85
 
WORKS CITED ...........................................................................................................................88
 
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 4
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 5 
ABBREVIATIONS/ACRONYMS 
 
AED Academy for Educational Development 
AIDS Acquired Immunodeficiency Syndrome 
ART Anti-retroviral Therapy 
BCC Behavior Change Communication 
CBO Community-Based Organizations 
CDC Centers for Disease Control and Prevention 
CITC Client-Initiated Testing and Counseling 
CLEAR Choosing Life, Empowerment, Action, Results 
FHI Family Health International 
HIV Human Immunodeficiency Virus 
HTC HIV Testing and Counseling 
IEC Information Education Communication 
IDU Injection Drug User 
IOM Institute of Medicine 
I-RARE International Rapid Assessment, Response, and Evaluation 
JHU Johns Hopkins University 
NCETA National Centre for Education on Training and Addiction 
NIDA National Institute on Drug Abuse 
NIDU Non-Injection Drug User 
NSE Needle and Syringe Exchange Programs 
NYDOH  New York State Department of Health  
OSI Open Society Institute 
PITC Provider-Initiated Testing and Counseling 
PMTCT Prevention of Mother to Child Transmission 
PWID People who Inject Drugs 
PWUD People who Use Drugs 
SHIELD Self-help in Eliminating Life-Threatening Diseases 
SAMHSA Substance Abuse and Mental Health Services Administration 
STI Sexually Transmitted Infections 
TB Tuberculosis 
UNAIDS Joint United Nations Programme on HIV/AIDS 
UNHCR United Nations High Commission on Refugees 
UNODC United Nations Office on Drugs and Crime 
VCT Voluntary Counseling and Testing 
WHO World Health Organization 
   
  
     
     
 
 
   
      
  
  
  
   
   
   
    
     
   
  
 
   
     
   
    
 
 
      
   
   
       
   
 
  
    
   
    
  
  
    
    
 
 
  
  
    
   
     
    
      
CHAPTER 1: ABOUT THIS TOOLKIT
People who use drugs (PWUD), including people who inject drugs (PWID), are marginalized and 
stigmatized in most societies; and often are at increased risk of acquiring and transmitting HIV,
Hepatitis, and other blood-borne pathogens.1 These populations are hard to reach and often,
least able to access and least likely to utilize HIV prevention, care, and treatment services.
Therefore, HIV prevention programs need to be developed or tailored to effectively target, reach,
and address the particular needs of PWUD.
International and national organizations such as the World Health Organization (WHO), the joint
United Nations Programme on HIV/AIDS (UNAIDS), the Centre for Harm Reduction, and the
National Institute on Drug Abuse (NIDA) have developed high-quality materials (e.g., guidelines,
manuals, protocols, and training curricula) to guide the provision of HIV-related prevention 
services to people who use and/or inject drugs. These materials currently exist in many different
formats and have been developed with a variety of target audiences and program foci in mind.
This toolkit has been developed to serve as a guide to available resources on HIV prevention 
among drug-using populations.
Aim of the Toolkit
 The toolkit aims to provide an overview of tools and resources for key, effective interventions and 
planning programs for PWUD, including designing and implementing programs, monitoring and 
evaluating program progress and outcomes, and supporting and developing effective drug and 
HIV policy.
Target Audience
 Persons responsible for guiding, developing, and implementing policy and programs to prevent
HIV among drug-using populations including, but not limited to, Chiefs of Party, Country Directors, 
Ministries of Health, multi-sectoral government staff and professionals involved in HIV/AIDS
prevention, members of non-governmental (NGO) and community-based (CBO) organizations,
clinicians, and other persons who provide direct services to PWUD.
Methods
 Keyword searches were conducted of Web sites, relevant published literature, and other
published and unpublished sources, including reports, manuals, and other materials. Search 
terms included, “injection and non-injection drug users (IDU and NIDU), HIV/AIDS, substance 
abuse, substance abuse treatment, and HIV prevention care and treatment.” The objective was to 
identify recent (published after 2000), relevant tools and materials that address HIV prevention 
among drug-using populations. The focus was on locating and compiling practical tools,
guidelines, reports, and other resource documents. Select review articles are included that
provide evidence for various HIV prevention interventions among drug-using populations.
How to Use This Toolkit
 The toolkit is divided into chapters based on program development and the core complementary
interventions that make up a comprehensive HIV/AIDS prevention program for drug users.  Each
section provides a summary of major principles and a list of related tools and resources. These 
tools and resources are relevant to, and expand upon, principles, evidence, and information
presented in each chapter. A list of works cited is presented, followed by an annotated list of all
the tools mentioned, at the end of the document in Appendix 1.
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 6
   
  
   
    
  
  
   
  
 
  
     
    
   
 
   
 
 
  
  
   
CHAPTER 2: BACKGROUND AND OVERVIEW OF DRUG USE AND HIV
Drug Use and HIV 
One hundred, seventy-two to two hundred, fifty million people aged 15–64 report using illicit drugs
at least once in the last year. Of these, 18–38 million are “problem drug users”.2 Problem drug
users are those who consume most of the drugs used each year, are very likely dependent on 
drugs, and would benefit from treatment. Considerable regional, country, and local variation 
occurs in the prevalence and patterns of drug use, the route of administration (e.g., injecting, 
snorting, and/or smoking), and the settings in which drugs are used. There are an estimated 15.9 
million injecting drug users in 148 countries where use of injecting drugs has been documented 
and the global prevalence of injecting drug use is shown below.3
Figure 1: Prevalence of Injecting Drug Use3 
HIV/AIDS in people who use drugs is a global public health problem, as demonstrated by the
large number of PWUD living with HIV. An estimated three million people who inject drugs may be 
HIV positive.3 Five to ten percent of HIV/AIDS cases worldwide are attributed to injection drug 
use.4,5 Regional statistics have emerged estimating the proportion of HIV cases attributable to
injection drug use. In Eastern Europe and Central Asia, an estimated 54% of all HIV infections are 
a result of injection drug use. In Latin America and the Asia Pacific region, the proportion of HIV
infections estimated to be from injection drug use is 3% and 30%, respectively.6 
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 7
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HIV Risk among People who Use Drugs
Drug users are at increased risk of acquiring and transmitting HIV due to drug- and sex-related 
HIV risk behaviors.
Drug-Related HIV Risk
HIV epidemics spread rapidly among drug users because of the increased exposure to the virus
through the sharing of contaminated drug-injection equipment (e.g., needles, syringes, and
cookers). Several reasons exist for the sharing of equipment such as: 1) group norms and rituals,
2) difficulty in obtaining clean equipment (i.e., cost and availability), and 3) inability to keep and 
maintain one’s own injection equipment due to household, social, or legal environments.7 Needles
are more efficient in transmitting HIV because they provide a direct route from an infected 
person’s blood to a non-infected recipient’s blood. Also people who inject drugs tend to inject
frequently (multiple times daily), which increases their risk of acquiring and transmitting HIV, viral 
hepatitis, and other blood-borne pathogens.1
Sex-Related HIV Risk
PWUD and PWID also transmit and acquire HIV through high-risk sex behaviors. People who use 
and/or inject drugs may be sexually active with male and/or female sex partners. Since drugs can
impair judgment, drug use has been associated with increases in high-risk sexual behaviors,
including engaging in unprotected sex, having multiple and often high-risk sex partners, and
exchanging sex for money or drugs.1
Mother-to-Child Transmission
When a HIV positive female drug user becomes pregnant and gives birth to a child, it is possible 
that HIV can be transmitted from the mother to the child. This type of risk is lessened if the HIV-
positive female drug user knows her status, receives anti-natal care, and prevention of mother-to-
child transmission services.
To effectively limit the acquisition and transmission of HIV among PWUD, a comprehensive 
prevention program is needed, which begins with an understanding of the population, specific HIV 
risks related to drug use, and the effective interventions for reducing HIV among PWUD.
The tools and resources in this section provide background on the HIV/AIDS and drug use.
Tools and Resources: Background and Overview of Drug Use and HIV
Tool 2.1 Aceijas et al. (2004): Global overview of injecting drug use and HIV infection among 
injecting drug users.
Tool 2.2 CDC (2007): Drug Use and HIV Curriculum
Tool 2.3 IOM (2006): Preventing HIV Infection among Injecting Drug Users in High Risk
Countries: An Assessment of the Evidence
Tool 2.4 Mathers et al. (2008). Global epidemiology of injecting drug use and HIV among people
who inject drugs: a systematic review.
Tool 2.5 Special Issue, African Journal of Drug and Alcohol Studies (2006): Substance 
Abuse and HIV/AIDS in Sub-Saharan Africa
Tool 2.6 UNODC (2008): World Drug Report 2008
   
   
  
          
    
    
 
  
   
  
 
  
  
     
  
   
    
    
   
 
      
  
   
    
   
   
 
  
 
  
   
   
 
  
    
      
      
       
    
   
      
  
      
   
     
 
   
   
   
    
      
  
     
CHAPTER 3: ASSESSING THE LOCAL DRUG USE CONTEXT
Effective programs are based on an understanding of who is using drugs, which drugs are being 
used, what kinds of risk behaviors are related to drug use (e.g., sharing injection equipment and
increased frequency of unprotected sex) and what steps need to be taken to reach out and
encourage PWUD to engage with HIV prevention activities and services. 
Review existing data
Reviewing existing data is a necessary first step. Search the published and unpublished (“grey”)
literature for relevant studies that describe the epidemiology of drug use and of HIV among 
people who use drugs in the area. Search the Internet and ask stakeholders for unpublished 
reports that may provide important detail and background on the context of drug use in the area 
or region. Review any data from epidemiological studies and behavioural surveillance surveys
that may have been conducted among people who use drugs. When possible, the following
sources of data should be reviewed: surveys (DHS, KAIS, BSS, etc.), qualitative studies
(ethnographic research, rapid assessment, needs assessment, formative assessment, etc.),
program/operational research, policy briefs, and best practices literature. This information will help
program planners get a broad picture of HIVSTI and drug use in the area, and an understanding
of what is already known.
Often, there are no existing data that are useful for tailoring services. Epidemiological data may
have information about prevalence but may not be able to explain why PWUDs will not use
services. Therefore, it may be necessary to collect qualitative data to better understand where 
PWUDs congregate and how to approach them. Quantitative data in the form of size estimation 
may be needed to determine what resources are needed. Since drug use is illegal, and PWUDs
are often marginalized, collecting data on drug use can be challenging; however, this can usually
be accomplished through a participatory process that includes PWUDs and community members
familiar with the population in planning. 
What should be assessed?
When trying to understand the HIV prevention needs of people who use drugs in a particular area, 
program managers should have an understanding of the following issues:
 Description of local population that uses drugs
 Characteristics of people who use drugs (age, gender, race/ethnicity, etc.)
 Types of drugs used (e.g., heroin, methamphetamine, and cocaine)
 Modes of drug use (smoking, injecting, snorting, etc.)
 Sexual and drug use related risk behaviors (e.g., sharing equipment and unprotected sex)
 Social and cultural context of drug use
 Information related to services for people who use drugs
 HIV prevention care and treatment services for people who use drugs
 Drug treatment services 
 Barriers and facilitators to using HIV prevention, care, and treatment services
 How people who use drugs feel about the available services
 Policy and regulatory factors that affect provision or use of services
Description of People who use Drugs
This process includes identifying who is using drugs, the types and amounts of drugs used, how
the drugs are used, drug- and sexual-related risk behaviors, and the social and cultural context
within which drug use and HIV occurs.8 The mode of drug use is important in assessing HIV risk
because people who inject drugs are at higher risk of contracting HIV than people who use drugs
but do not inject. At the same time, some drugs that are smoked or ingested, such as crack 
cocaine and methamphetamine, have been associated with high-risk sexual behaviors such as
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 9
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unprotected anal and vaginal sex and higher numbers of sex partners. Understanding where,
when, and how drugs are used in a particular social and cultural context is important for
developing strategies that reach people who use drugs and for placement of interventions and 
services. This information also enables program planners to locate key community members who 
are knowledgeable about the population and existing resources that can later be incorporated and 
used in developing and implementing interventions.
Information about Services for People who use Drugs
It is also important to understand factors related to HIV prevention, care, and treatment services,
including the kinds of services currently available, whether the services are user-friendly (i.e.,
appropriate, accessible, and acceptable and affordable to PWUD), and the policy and regulatory
context within which drug use and HIV transmission occur and interventions will be implemented.
For example, in environments in which drug possession, use, or drug paraphernalia are
criminalized, people who use drugs may be reluctant to access HIV prevention and other health
services. There may also be policies that prevent HIV-positive drug users from accessing care. It 
will be important for program planners to understand which laws exist and which behaviors the 
laws criminalize (e.g., drug possession, drug use, etc.).  Understanding the policy and legal
environment will provide insight into potential barriers to implementation and uptake of services.
Methods Used to Describe and Characterize the Local Context: Formative Research, Rapid
Ethnographic Assessment, and Size Estimation
Formative research
As mentioned earlier, it may be necessary to collect exploratory data to better understand who 
comprises the population, where drug using takes place, and how PWUD feel about existing 
services. Sometimes this phase is referred to as, “formative,” because the data are used to inform
the design of the program. Formative research can be limited to asking a few simple questions or
can be more complex. Formative research often incorporates qualitative methods and can be
conducted using a rapid assessment approach.
Rapid ethnographic assessment
Rapid ethnographic assessment is a team-based, multi-method data collection and analysis
approach that typically includes members of the target population (e.g., current and former
PWUDs) as part of the planning and data collection team. A strength of rapid ethnographic
assessments is that they draw on principles of ethnography in eliciting the perspective of persons
on “the inside”; that is, they seek to understand drug use from the view of those who use drugs or
are involved in some aspect of drug use. Interviews and focus groups can be conducted with 
small samples of PWUD, persons involved in the drug trade, families and partners of PWUD, 
outreach workers, and service providers, as needed. Structured observations at different times of
the day or night will help planners identify key locations and know where and when to send
outreach workers. Mapping will provide information about where activities such as drug using and
drug dealing take place, and identify potential barriers to services such as the location of police 
stations or patrols. 
Rapid assessments can vary in size and scope depending on the needs of the program. In cases
where there are no existing data, an assessment with a broader scope may be needed. Ongoing
programs may find it useful to conduct smaller, periodic assessments to monitor emerging trends
such as what new drugs are appearing in the market. Either way, it is important to keep in mind 
that rapid assessments will require training and expertise in qualitative data collection and 
analysis and should be conducted in conjunction with program staff and members of the target
population. 
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Estimating the Size of Drug-Using Populations
Once the population of drug users has been identified and described, it may be useful to estimate 
how many there are in a given geographic area (e.g., catchment area, city, region, etc.). Size
estimates can be used to determine the magnitude of the problem, to evaluate how well the 
program is reaching the target population, and to advocate for needed resources.9 Before 
conducting size estimation, the program should determine how the population will be defined, how
the data will be used, and when the results of the estimation are needed. Since drug-using 
behaviors are often hidden, obtaining accurate estimates of the numbers of drug users in any 
setting may be a challenge. There are several approaches to estimating the size of drug-using 
populations. Some methods are based on data collected directly from the target population, while 
others are based on data collected from the general population. Program planners should review
the requirements, strengths and weaknesses of various methods, and select the appropriate 
methods for their purposes. Program planners should also review any existing size estimates that
have been carried out. In some instances, it may be useful to use more than one method. Size-
estimation methods, most often used to estimate the size of hidden populations, include the
following:9 
 Census and enumeration
 Capture-recapture
 Multiplier
 Surveys
 Network scale-up 
Programs should exercise caution when using or publicizing the results of size estimation 
because focusing attention on these behaviors may lead to negative or punitive responses from
government, law enforcement, or citizens. Above all, programs should strive to “do no harm.” 
Sampling Strategies for Drug-Using Populations
Since drug use is often criminalized and stigmatized, persons who use drugs are often hidden,
making it difficult to find and recruit them for behavioral and epidemiological studies. In most
cases, random sampling will not capture the population, however, several other sampling
techniques have proven to be successful in capturing hard-to-reach populations, such as venue-
based (time-location) sampling, snowballing, and respondent-driven sampling.10,52 
In venue-based or time-location sampling, researchers approach drug users at various times in 
locations they are likely to frequent, such as shooting galleries, public parks, and other known 
drug-dealing and -using locations. The limitation of this method is that it targets only those people 
who use drugs who are readily accessible and may not represent an accurate cross-section of
PWUD.
Snowball sampling achieves broader coverage as PWUD are accessed through their social
networks, thus facilitating contact with individuals who may not frequent typical venues but who 
are referred to the study by other participants. This approach is non-random and does not provide 
generalizable information about all PWUD in that community.
Respondent-driven sampling is a network sampling approach that has been used to collect
representative data among socially networked members of hidden populations. It is a variant of
chain-referral methods in which an initial, non-random set of participants (seeds) help recruit
successive waves of participants until the sample size is reached. The combination of snowball
sampling and statistical weighting helps to compensate for the non-random nature of snowballing. 
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Rapid ethnographic assessment and qualitative studies typically rely on small, non-probability
samples. Since the goal of these studies is to achieve depth, rather than breadth, key informants
are selected based on variables of interest and their knowledge and willingness to talk about a
particular topic. Participants are often recruited through snowball or chain-referral sampling.
Sample size is based on the principle of saturation—the point at which no new information is
being learned through interviews.
Considerations for Assessing the HIV Prevention Needs of People who Use Drugs
Multiple research methods and data collection tools can be used to describe people who use 
drugs, assess the extent of drug use and HIV prevalence, and determine HIV prevention care and 
treatment needs. However, institutions and organizations may lack the specific skills needed to 
address hard-to-reach populations. Therefore, programs should consider which data collection
methods are appropriate for their questions, and how the data will be used. In addition, programs
need to consider the institutional capacity available to use the chosen method. Finally, programs
should take care to maintain the privacy, safety, and trust of participants and ensure that data
collected is accurate and ethically sound.
The tools and resources in this section provide information on methods of documenting and 
describing HIV risk behaviors among PWUD, determining the prevalence of HIV among PWUD,
and determining the size of drug-using populations.
Tools and Resources: Assessing the HIV Epidemic among People who use Drugs
Tool 3.1 CDC (2007): International Rapid Assessment, Response, and Evaluation (I-RARE)
Curriculum: Methods and Analysis Training for Field Teams: Using Rapid Assessment
Methodologies and Qualitative Analysis Techniques to Understand and Respond to the HIV
Epidemic in Drug Using Populations
Tool 3.2 Journal of Urban Health Supplement (2006): Special Issue on Respondent Driven
Sampling
Tool 3.3 Stimson, Hickman, Rhodes, Bastos, and Saidel (2005): Methods for Assessing HIV and 
HIV risk among IDUs and for evaluating interventions
Tool 3.4 UNAIDS/WHO (2010): Estimating the size of populations most at risk to HIV. 
Tool 3.5 UNAIDS/IMPACT/FHI (2003): Estimating the Size of Populations at Risk for HIV
Tool 3.6 UNHCR (2008): Rapid Assessment of Alcohol and Other Substance Use in Conflict-
affected and Displaced Populations: A Field Guide
Tool 3.7 UNODC (2003): Developing an Integrated Drug Information System: Global
Assessment Programme on Drug Abuse
Tool 3.8 WHO (2003): Rapid Assessment and Response Guide on Psychoactive Substance Use 
and Sexual Risk Behaviour
Tool 3.9 WHO (1998): Rapid Assessment and Response Guide on Injection Drug Use (IDU-RAR)
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CHAPTER 4: PLANNING COMPREHENSIVE HIV PREVENTION 
PROGRAMS FOR PEOPLE WHO USE DRUGS
After characterizing the HIV epidemic among PWUD, planning for HIV prevention interventions for
these populations can begin. HIV prevention programs among PWUD should aim: 11 
 To reduce or eliminate drug-related risk behaviors that contribute to HIV transmission and
acquisition, including unsafe drug preparation and injection practices.
 To reduce or eliminate sex-related risk behaviors contributing to HIV transmission and 
acquisition, including unprotected anal, vaginal, and oral sex with multiple partners.
Program Development
As the HIV/AIDS epidemic is fluid, programs will need to adapt to changing circumstances by
using a strategic approach to plan HIV prevention programs for PWUD that is periodically
reassessed taking the following into consideration:12 
 The current HIV/AIDS situation among PWUD
 The current public health response to HIV/AIDS among PWUD
 Key barriers to current responses
 Areas for improvement of current responses
 Available and potential resources
 Most important factors and programmatic priorities
A strategic approach to HIV/AIDS program development will include well-defined goals, priority
objectives, key strategies, and associated resources (monetary and human) to reach these
objectives, as well as a defined set of targets and indicators.
HIV/AIDS Prevention Program for People who use Drugs
Effective HIV prevention programming for PWUD ensures the participation of members of the 
community in program development, implementation, and management. Members of the
community include PWUD/PWID, their sexual and drug use partners, and surrounding 
community. The multi-component, HIV prevention program (described below) includes
interventions that address multiple health issues related to HIV, such as TB, STIs, and Hepatitis B
and C. To ensure PWUD have access to these services, it will be important to consider
establishing a strong referral network as well as various service delivery models including:
Program collaboration— a mutually beneficial and well-defined relationship between two or
more programs. It requires a strong referral network to ensure programs effectively collaborate to 
deliver services to the individual.
Co-location of services—provides different services in the same physical location. These 
services require different registration procedures and have separate records for individuals that
are not linked to each other.
Service integration—a distinct method of service delivery that provides the individual with 
access to services from multiple programs without repeat registration procedures or other
administrative barriers.13 
Principles in Service Delivery to People who Use Drugs
Along with a variety of service-delivery models, HIV prevention programs for PWUD need to be
user-friendly. User-friendly services are appropriate, accessible, acceptable, and affordable.
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• Appropriate Services
Interventions must be culturally appropriate and based on the needs of the local, drug-using
population. Therefore, PWUD should be involved in all stages of program planning and 
implementation to ensure interventions are timely, appropriate, and respond to the current
needs of the population. Also, service providers should be trained on the specific health needs
of PWUD (e.g., wound care from injecting practices).
• Accessible Services
Accessible health services are conveniently located (e.g., near the identified “hotspots”) and
open at hours that are acceptable to PWUD. Accessible interventions limit the number of
logistical barriers, thereby increasing the number of individuals seeking health services.
Whenever possible, services should be integrated and/or co-located to expand the coverage 
for a broader range of health services accessed in a single visit.
• Acceptable Services
Service providers and program implementers must adopt a non-judgemental and non-
stigmatizing attitude, as well as be trained in dealing with the special needs of PWUD.
Services must be confidential and voluntary to ensure the health and human rights of PWUD
are maintained. Any health services provided to PWUD must also be in line with international
standards and current best-practices and guidance within the country.
• Affordable services
People who use and inject drugs are usually financially disadvantaged and may not view HIV
prevention as an economic priority. Therefore, programs should consider who comprises the
local, drug-using population and their ability to pay for services. In many cases, services may
need to be free or subsidized to overcome financial difficulties faced by PWUD.
Comprehensive HIV Programs for PWUD
HIV prevention among PWUD should focus both on individual risk behaviors and the HIV-risk
environment. Evidence has shown the fundamental components (detailed in Chapter 5) of a
comprehensive, complementary, HIV prevention program for drug users include the following:
• Community-based outreach
• Risk reduction counseling and behavior change interventions
• HIV testing and counseling
• Condom distribution and promotion
• Access to, and safe disposal of, injection equipment
• STI screening and treatment
• HIV care and treatment
• Treatment for drug use and dependence
• Prevention, diagnosis, and treatment of Tuberculosis (TB)
• Vaccination, diagnosis, and treatment of viral hepatitis14 
In conjunction with the above services, referrals to appropriate social services (i.e., shelters,
employment assistance, etc.) should be provided. These services help to provide the supportive 
environment that is usually needed for PWUD to assimilate back into the community.
HIV prevention interventions for PWUD need to address the overall HIV risk environment as well
as individual risk behaviors by advocating for increased access to health services and removal of
barriers. This is done by advocating for a policy environment in which PWUD have the ability to 
access health care without criminalization and stigmatization. HIV programs may need to 
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negotiate with local authorities to address issues that negatively impact health care access. Both 
individual-level and environmental-level interventions are needed to prevent and treat HIV among
PWUD.
The following tools and resources provide information on designing HIV prevention programs and 
interventions for PWUD.
Tools and Resources: Planning Comprehensive HIV Prevention Programs for PWUD
Tool 4.1 AED (2000): A Comprehensive Approach: Preventing Blood-Borne Infections among 
Injection Drug Users
Tool 4.2 Center for Harm Reduction (2003): Manual for Reducing Drug-Related Harm in Asia 
Tool 4.3 FHI (2001): HIV/AIDS Prevention and Care in Resource-Constrained Settings: A
Handbook on for the Design and Management of Programs.
Tool 4.4 National AIDS Control Organization: Government of India (2007): Targeted Interventions
Under NACP III: Operational Guidelines
Tool 4.5 NIDA (2002): Principles of HIV prevention in drug-using populations: A research-based 
guide 
Tool 4.6 NYDOH AIDS Institute (2009): HIV and Substance Use Clinical Guidelines: Working with 
the Active User
Tool 4.7 OSI (2008): Harm Reduction Developments: Countries with Injection-Driven HIV
Epidemics
Tool 4.8 Regional Office for the Eastern Mediterranean/WHO (2004): Best practice in HIV/AIDS
prevention and care for injecting drug abusers: The Triangular Clinic in Kermanshah, Islamic
Republic of Iran 
Tool 4.9 UNAIDS (2006): High Coverage Sites: HIV Prevention among Injecting Drug Users in 
Transitional and Developing Countries
Tool 4.10 UNODC South Asia: Prevention of HIV among Drug Users in the South Asian
Association for Regional Co-operation (SAARC) Countries
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CHAPTER 5: IMPLEMENTING HIV INTERVENTIONS AMONG PEOPLE
WHO USE DRUGS
As previously mentioned, a comprehensive, multi-component, HIV prevention program is the most
effective approach for preventing the transmission and acquisition of HIV among drug-using 
populations. The comprehensive, multi-component, HIV prevention program is based on
principles of harm reduction. Harm reduction is a pragmatic and humanistic approach to reducing 
the harms (especially the risk of HIV and other blood-borne pathogens) to the individual and 
society from drug use. The aim is to reduce the adverse health and social effects of drug use 
through activities and approaches that safeguard the dignity, humanity, and human rights of
PWUD. Harm reduction principles are based on the recognition that there is no known effective 
intervention for eliminating drug use or drug-related harms and, therefore, no current means for a 
community to be completely drug free. Harm reduction recognizes that, for many PWUD,
becoming drug free is a distant and long-term goal. Therefore, programs address the needs of
PWUD by understanding where they are on the continuum of behavior change and helping the 
PWUD reduce the acquisition and transmission of HIV and other blood-borne pathogens. This
may not result in a person completely abstaining from drugs, but will reduce personal and societal
public health harm. All the HIV prevention interventions for PWUD/PWID detailed below are 
based on reducing public health harm to the individual and larger society.13 
5.1 Community Outreach
The goal of community outreach is to help PWUD reduce their drug-related HIV risk and to 
decrease HIV transmission among PWUD and their partners. Community outreach workers
typically make contact with PWUD in their community to provide HIV prevention information, risk
reduction counseling and supplies (e.g., bleach kits and condoms), and referrals and/or links to 
VCT, STI, HIV care and treatment, and drug treatment services.1 Community-based outreach is a 
low-cost, effective intervention, well-suited for settings with limited resources and can be rapidly
scaled up.1 Evidence shows that high-quality community outreach programs can be effective in:
1) Reducing frequency of drug use
 
2) Reducing injection frequency

3) Reducing frequency of sharing needles and other injection equipment
 
4) Increasing needle disinfection
 
5) Increasing condom use
 
6) Increasing entry into drug treatment programs16,17
 
Evidence also shows that people who use drugs, who make contact with community outreach
workers, are more likely to accept HIV counseling and testing and access and enter drug
treatment programs.15,16 
Outreach workers typically reside in the PWUD’s community and may be current or former drug 
users. Current PWUD facilitate entry into the drug-using network, especially among PWID.  These 
workers can easily contact injecting peers and are more positively received by drug-using 
networks. Through a process of engagement with people who use drugs, outreach workers carry
out HIV risk assessments, transfer risk reduction skills and support behavior change to reduce or
eliminate high-risk practices and facilitate entry into services. Community outreach with people 
who use drugs usually includes establishing initial contact and making repeated contacts over
time in order to establish rapport and trust. Outreach workers make contact with PWUD by 
working in venues frequented by PWUD, such as bars, shooting galleries, and crack houses.
Outreach workers are trained on the strategies for accessing hard-to-reach populations and
recognizing and dealing with changing drug-use behaviors.
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The tools and resources below provide guidance on implementing community outreach programs
as well as provide training guides for outreach workers.
Tools and Resources: Community Outreach
Tool 5.1.1 National Institute on Drug Abuse (2000): The NIDA Community-Based Outreach Model:
A Manual to Reduce the Risk of HIV and Other Blood-Borne Infections in Drug Users
Tool 5.1.2 Needle et al (2005): Effectiveness of community-based outreach in preventing HIV/AIDS
among injecting drug users.
Tool 5.1.3 Valentine and Wright-De Aguero (1996): Defining the components of Street Outreach for
HIV Prevention: the Counter and Encounter
Tool 5.1.4 WHO (2004): Evidence for Action: Effectiveness of Community Based Outreach 
Tool 5.1.5 WHO/UNAIDS/UNODC (2004): Policy Brief: Reduction of HIV Transmission through 
Outreach 
Tool 5.1.6 WHO (2004): Training Guide for HIV Prevention Outreach to IDUs: WHO Workshop 
Manual
5.2 Risk Reduction Counseling and Behavior Change Interventions
Risk Reduction Counseling
The goal of risk reduction counseling and behavior change interventions is to reduce the negative
health consequences associated with certain health risk behaviors. Risk reduction for PWUD
should address both drug and sexual risk behaviors. For people who inject drugs, the focus of risk
reduction has been on reducing drug-use practices, such as sharing injection equipment and
improper cleaning and disposal of injection equipment that contribute to blood-borne disease 
transmission.14 However, most PWUD have sex partners and some non-injection drugs, such as
cocaine and methamphetamine, that are associated with higher frequencies of sexual risk
behaviors.15 Both injecting and non-injecting drug users should be counseled regarding sexual
risk behaviors and advised to avoid having unprotected anal or vaginal sex, sex with multiple or
known high-risk partners, and to use condoms correctly and consistently.
Harm reduction, as mentioned above, is an approach used by many countries to address the 
detrimental health effects of illicit drug use, especially injection drug use, without necessarily
requiring reduction in overall drug consumption. Risk reduction is a strategy used within a harm
reduction approach. Risk reduction addresses the potential public health impact of illicit drug use 
by involving PWUD and prioritizing short-term behavioral goals that prevent or interrupt disease
transmission rather than longer term goals. These short-term goals are often based on a
hierarchy of HIV/AIDS risk reduction strategies, including those that require dramatic changes in
behavior (stop using drugs) to less dramatic but nonetheless important changes (cleaning
injection equipment) that will reduce the likelihood of acquiring or transmitting HIV and other
blood-borne pathogens.  
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Figure 2: Hierarchy of HIV/AIDS Risk Reduction Messages for IDUs10 
STOP USING DRUGS
STOP INJECTING DRUGS
DO NOT SHARE DRUG
INJECTION EQUIPMENT
RE-USE
OWN EQUIPMENT ONLY
CLEAN INJECTION
EQUIPMENT
THROUGHLY
SAFELY DISPOSE OF
INJECTION
EQUIPMENT
AFTER USE
Risk reduction counseling can take place in a variety of settings and through different modes of
delivery, including through community outreach workers in the field or in health care settings. In 
general, risk reduction counseling for PWUD includes some or all of the following: provision of
information on HIV/STI transmission, assessment of personal risk and responsibility, access to
risk reduction supplies (e.g., sterile syringes and condoms), and skills training (condom
negotiation and syringe cleaning). Interventions should also include referral to HIV testing and
counseling, STI screening and treatment, HIV care and treatment for HIV-positive drug users, and 
drug treatment, if available. High-quality community outreach programs that include risk reduction 
counseling, supplies, and referrals can be easily implemented and scaled up in resource-
constrained settings.
Behavior change interventions
Interventions to reduce drug and sexual risk taking can range from relatively straightforward 
delivery of information and supplies to more complex or structured behavior change interventions
that are based on cognitive behavioral and social theories such as the Social Learning Theory,
Self-Efficacy Theory, and Diffusion of Innovation Theory. These interventions may involve multiple
sessions or components, and may target individuals, groups, communities, or be multi-level in
design.16 The content of interventions varies, but generally they include components that address
personal and technical skills building, personal goal setting, and provision of social and emotional
support. More complex behavioral interventions for PWUD are also available, and there are a 
number of interventions with drug users that have demonstrated substantial evidence of efficacy
in reducing HIV and STI risk.17 Most of these interventions have been developed in the United 
States in research settings and have not been used in resource-constrained settings. These 
interventions may require adaptation for the local setting and additional training and capacity
building to be implemented correctly.18 
   
 
     
 
 
  
     
   
 
 
   
 
 
     
 
   
 
 
   
  
 
 
 
 
 
    
  
 
    
 
 
   
 
    
 
 
    
   
 
     
  
 
  
  
 
    
 
 
   
   
 
   
   
 
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 19
Tools and resources on risk reduction and specific behavior change interventions for PWUD are 
provided below.
Tools and Resources: Risk Reduction Counseling
Tool 5.2.1 Afser, Mohamed, AAHUNG, National AIDS Control Programme, Ministry of Health,
Government of Pakistan & Futures Group (2007): Guidelines for Behavior Change Communication:
Enhancing Content for Harm Reduction Service Provision 
Tool 5.2.2 Aggleton, Jenkins, and Malcolm (2005): HIV/AIDS and injecting drug use: Information,
education and communication
Tool 5.2.3 Canadian AIDS Council (2004): HIV Transmission Guidelines for Assessing Risk
Tool 5.2.4 CARE/UNAIDS (2003): Guidelines for Behavior Change Interventions to Prevent HIV:
Sharing Lessons from an Experience in Bangladesh 
Tool 5.2.5 Des Jarlais and Semaan (2005): Interventions to reduce the sexual risk behaviour of
injecting drug users
Tool 5.2.6 International Federation of Red Cross and Red Crescent Societies (2003): Spreading 
the Light of Science: Guidelines on Harm Reduction Related to Injection Drug 
Use   
Tool 5.2.7 Semaan, Des Jarlais, and Mallow (2006): Behavior Change and Health-Related 
Interventions for Heterosexual Risk Reduction Among Drug Users
Tool 5.2.8 WHO, Regional Office for South-East Asia, and Regional Office for the Western Pacific
(2005): Bi-regional Strategy for Harm Reduction 2005-2009: HIV and Injecting Drug Use 
Tools and Resources: Behavioral Interventions
Tool 5.2.9 AED/CDC (2006): Safety Counts Program Manual: A Cognitive-Behavioral Intervention 
to Reduce HIV/Hepatitis Risks Among Drug Users Who Are Not in Drug Treatment 
Tool 5.2.10 CDC (2006): Provisional Procedural Guidance for Community-based Organizations
Tool 5.2.11 JHU/NIDA (1997): Self Help in Eliminating Life-Threatening Diseases (SHIELD)    
Tool 5.2.12 Lyles et al/CDC (2007): Best Evidence Interventions: Findings from a Systematic
Review of HIV Behavioral Interventions for US populations at High Risk, 2000–2004
Tool 5.2.13 NIDA/University of California: Los Angeles (2000): Choosing Life; Empowerment,
Action, Results (CLEAR)
Tool 5.2.14 Sterk and CDC (1998): Female and Culturally Specific Negotiation Intervention 
Training Manual
Tool 5.2.15 Yale/CDC (2004): Holistic Health Recovery Program Manual
5.3 HIV Testing and Counseling
HIV testing and counseling (HTC) allows individuals to learn their HIV status, as well as receive 
counseling and support in coping with a positive or negative result. HTC includes pre-test 
information to enable individuals to make an informed decision to be tested and tailored 
counselling to cope with a positive or negative test result. The level of post-counselling depends
on the type of HTC implemented and is discussed further below.
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Types of HTC
•	 Client-initiated HIV testing and counseling (CITC) refers to a situation whereby an 
individual, couple, or group actively seeks out HIV testing and counselling at a site where 
these services are provided. CITC puts emphasis on tailored risk assessment and
reduction counselling. In generalized epidemics, it is reccomended that CITC should be 
made widely available using a variety of service delivery modalities. In low-level or
concentrated epidemic settings, focus should be on increasing access and uptake among
most at-risk populations (MARPs), such as PWUD and other vulnerable populations.19 
•	 Provider-initiated HIV testing and counselling (PITC) in health facilities is a model of
HIV testing and counseling in which the health care provider offers and recommends HIV
testing to patients as a standard component of medical care. In generalized epidemic
settings, it is recommended that all patients be offered the opportunity to test. In low-level 
or concentrated epidemic settings, patients with signs or symptoms of HIV should be 
offered a test, along with patients in the following settings: STI clinic, TB clinic, ANC and 
labor and delivery, and health services for MARPs (e.g., PWUD/PWID). Counseling is
limited during PITC, therefore, program planners may need to refer PWUD to further
counseling depending on the individual’s need.20 
Settings for HTC
•	 Stand-alone HTC centers are facilities within the community that are not attached to other
specific health services and usually target the general population but can be tailored for
PWUD.
•	 Outreach HTC refers to services offered outside a fixed site (i.e., mobile vans, tents, etc.) 
and can be offered in the evening (referred to as moonlight HTC) or other times, which is
important when targeting PWUD.
•	 Home-based HTC is offered in the home of an individual. Home-based HTC provides high
coverage and increases acceptance of HTC in the general community.
•	 Health facility HTC can be initiated from any service delivery point in all sections of a
hospital/health facility for any person. PWUD should never be forced or coerced to receive 
an HIV test but should be routinely offered PITC during facility visits.
HTC and People who use Drugs
Evidence shows that HTC is an important intervention in and of itself because HIV-positive
persons who know their status are significantly more likely to reduce their HIV risk behaviors in 
order to protect HIV-negative partners.21 HTC also provides entry into HIV care and treatment and 
links to other important support services for those who test positive.22 
People who use drugs and/or inject drugs may be reluctant to be tested for HIV since their
behaviors are stigmatized and criminalized. Given their engagement in high-risk behaviors, many
PWUD are afraid of a positive HIV test result. PWUD lack confidence that health care providers
will protect their privacy and fear prosecution from law enforcement.23 
Therefore, it is crucial to enable PWUD/PWID to access HTC by removing barriers and
developing service delivery models that are accessible, affordable, and acceptable to
PWUD/PWID. Below are some of the motivators and barriers to VCT, as described by PWUD.
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Motivators and Barriers to VCT for People who Use Drugs27,24 
Motivators Barriers
Desire to protect partners Fear of being criminalized 
Understand benefits of early HIV diagnosis 
and treatment 
Fear of being dually stigmatized as HIV-
positive and a drug user
Access to drug treatment Concern about confidentiality
Convenient (walk in location, convenient
hours, no waiting)
Inconvenient (location, hours, long wait
times)
Rapid tests with rapid results Counseling messages inappropriate or
irrelevant to drug users
Assistance with disclosing to partners Dislike of venipuncture
For programs to be successful in increasing uptake of HTC by PWUD, it will be important to 
address local barriers to HTC. It will also be important to create an environment that enables
PWUD to know their status, including activities to limit further discrimination and stigma of HIV-
positive PWUD. Current guidance recommends retesting of HIV-negative PWUD every 6–12 
months or more frequently, depending on HIV risk behaviors.26 
Rapid HIV testing technology allows HIV tests to be conducted in a variety of settings (e.g.,
outreach and facility), allowing increasing access for PWUD to HTC. Advantages of rapid HIV
testing include:







HTC pro
transmis
messag
behavio
dual stig
The follo
resource
T
T
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A
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T
S    Ease of administration and interpretation   
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Increases confidence in test results as the test is conducted in sight of the drug user
Increases the number of people tested by utilizing alternative locations and service 
delivery models (e.g., outreach, home, and community settings)
Easily performed by non-laboratory personnel and in non-clinical settings
Provides short turnaround time for results, increasing the number of PWUD tested who 
receive their results
Facilitates earlier access to ARV treatment
Facilitates status disclosure to partners or family members26,29 
viders delivering services to PWUD should be trained to understand the routes of HIV
sion related to drug use. Risk assessment and risk reduction messages should include 
es specifically tailored to PWUD, and should address both drug- and sex-related HIV risk
rs. It is also important to train HTC providers to be non-judgmental and sensitive to the 
ma associated with being both a drug user and a person living with HIV/AIDS.
wing tools and resources provide a description on conducting rapid testing and PITC in
-poor settings as well as specific guidance on HTC for PWID.
ools and Resources: HIV Counseling and Testing
ool 5.3.1 WHO Southeast Asia Region and Western Pacific Region/UNODC Regional Centre for
ast Asia and the Pacific (2009): Guidance on Testing and Counseling for HIV in Settings
ttended by People Who Inject Drugs - Improving Access to Treatment, Care and Prevention
ool 5.3.2 WHO/UNAIDS (2007): Guidance on Provider-Initiated HIV Testing and Counseling in 
ealth Facilities
ool 5.3.3 WHO (2004): Rapid HIV Tests: Guidelines for Use in HIV Testing and Counseling 
ervices in Resource Constrained Settings
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5.4 Condom Distribution and Promotion
The goal of condom distribution and promotion is to provide PWUD with the information, supplies,
and skills to be able to use condoms correctly and consistently. Condoms, if used correctly and 
consistently, reduce HIV incidence by 80% and are one of the most effective ways to reduce the
sexual transmission of HIV/STIs.25 Prevention programs for PWUD should include access to
inexpensive (or free) male and female condoms and water-based lubricants. Prevention 
programs should also teach PWUD the skills necessary to negotiate condom use with sex
partners and use condoms correctly and consistently. Inconsistent condom use can lead to STI
acquisition because transmission can occur with a single act of intercourse with an infected 
partner.26 
Health service providers, community outreach workers, and others who may interact with PWUD
should be aware of the need to address sexual risk reduction among PWUD and provide support
for condom- and water-based lubricant use whenever possible.
The following tools and resources provide an background on condom effectiveness and principles
in condom programming.
Tools and Resources: Condom Promotion
Tool 5.4.1 UNFPA/WHO/UNAIDS (2009): Condoms and HIV Prevention: Position Paper
Tool 5.4.2 Weller, S. & Davis, K. (2002). Condom effectiveness in reducing heterosexual HIV
transmission
5.5 Access to and Safe Disposal of Injection Equipment
Access to sterile injection equipment (i.e., cookers, syringes, and needles) and safe disposal of
used injection equipment is an essential component of a comprehensive HIV prevention program
with PWID. Access to equipment can be facilitated by removing barriers that prevent PWID from 
buying equipment from pharmacies and other outlets and by implementing needle and syringe 
exchange programs (NSE). Access to sterile and safe injection equipment also includes access to
disinfection supplies (e.g., bleach).1 These interventions are targeted towards PWID who will not
or cannot stop injecting drugs, have no access to drug treatment, and/or are in treatment and
continue to inject drugs.
Evidence for the effectiveness of equipment access programs in reducing HIV transmission is
strong with no convincing evidence of any major or unintended negative consequences.27 
Injection equipment access programs are associated with self-reported reductions in sharing
needles, syringes and injection equipment, in unsafe injection and disposal practices, and
frequency of injection.1 
An important part of injection equipment access programs is providing disinfection supplies, such 
as bleach kits coupled with instructions on correctly disinfecting injection equipment before reuse
or disposal.28 The goal of disinfection activities is to reduce the risk of HIV by removing blood and
other organic matter through flushing followed by disinfecting the equipment to “kill” the remaining 
virus and other infectious agents. As part of this intervention, PWID are provided information on 
how to safely dispose of their injection equipment.
Some injection equipment access programs include NSE. Models for NSE vary; exchange can 
occur through a one-to-one exchange of a “dirty” needle/syringe for a “clean” needle/syringe or
through secondary exchange in which PWID distribute “clean” needles to other PWID. The latter 
exchange program reaches injection drug users that may not have access to one-to-one
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exchange sites. Needle exchange can be based out of drop-in centers, pharmacies, vending 
machines, or mobile centers and are either exchanged for free or bought by PWID.29 
As with all interventions for PWUD, access to, and safe disposal of, injection equipment should be
considered just one component of a linked or integrated set of complementary interventions that
comprise a comprehensive HIV prevention program. Further information on equipment access
and safe disposal are provided in the tools and resources listed below.
Tools and Resources: Access to and Safe Disposal of Injection Equipment
Tool 5.5.1 Burrows (2000). Starting and Managing Needle and Syringe Exchange Programs: A
guide for Central and Eastern Europe and the newly independent states of the former Soviet Union
Tool 5.5.2 CDC/AED (2004): Syringe disinfection for IDUs
Tool 5.5.3 WHO (2007): Guide to Starting and Managing Needle and Syringe Programmes
Tool 5.5.4 WHO (2004): Effectiveness of Sterile Needle and Syringe Programming in reducing 
HIV/AIDS among Injecting Drug Users
Tool 5.5.5 WHO (2004): Policy Brief: Provision of Sterile Injecting Equipment to Reduce HIV 
Transmission
Tool 5.5.6 Wodak and Cooney (2005): Effectiveness of sterile needle and syringe programmes
5.6 STI Screening and Treatment
Screening and treatment of STIs is an important component of HIV prevention programs for
PWUD. PWUD may engage in high-risk sexual behaviors including sex with multiple partners,
exchanging sex for drugs or money to buy drugs, and having unprotected anal and vaginal sex.
In addition, sexual mixing occurs between drug-using and non-drug-using populations and 
between injection and non-injection drug users. Finally, some non-injection drugs such as
amphetamines have been associated with increased sexual risk taking.30 
STIs have been associated with a two- to five-fold increase in HIV transmission and acquisition.31 
In HIV-positive persons, STIs increase genital viral shedding, which may increase HIV
transmission.32 Effective STI treatment has been shown to reduce shedding to baseline levels.33 
While evidence is mixed on the efficacy of STI treatment for reducing HIV transmission, 
particularly in high-prevalence countries34, treatment of STIs is important because STIs have 
serious adverse health consequences of their own, including neurologic disorders, ectopic
pregnancy, stillbirth, low birth weight, infertility, and cancers.
STI screening and treatment may include syndromic management and/or etiological screening to
determine the type of infection/disease and the appropriate treatment. In resource-constrained 
settings, syndomic management is common and includes history taking, education and
counseling on STIs, and information and skills to prevent future STIs (i.e., condom use and
negotiation skills).35 PWUDs need targeted STI screening and management programs that
promote access to STI services, treat symptomatic and, if feasible, asymptomatic STIs, link to 
HTC, other HIV services, and drug treatment. The following tools and resources provide an 
overview of STI screening and management in resource-constrained settings.
Tools and Resources: STI Screening and Treatment
Tool 5.6.1 AVAHAN India AIDS Initiative & Family Health International (2007): Clinic Operational
Guidelines & Standards: Comprehensive STI services for Sex Workers in Avahan-Supported 
Clinics in India
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Tool 5.6.2 WHO (2005): Sexually transmitted and other reproductive tract infections
Tool 5.6.3 WHO (2003): Guidelines for the Management of Sexually Transmitted Infections
Tool 5.6.4 WHO Regional Office for South-East Asia (2009):  Management of common health 
problems of drug users
Tool 5.6.5 Semaan et al - STD among illicit drug users in the US.pdf
5.7 HIV Care and Treatment
HIV care and treatment for PWUD includes anti-retroviral therapy (ART) for eligible individuals,
adherence support, and management of opportunistic infections and co-morbidities, as well as
access to primary health care. ART is as effective in PWUD as in other populations, in spite of the 
view held by many that PWUD are poor candidates for adherence to antiretroviral (ARV) drugs.1 
Provision of ART to drug-using populations is possible, especially if providers are supportive and 
familiar with the unique health and social needs of PWUD and are trained on interactions between 
ART and illicit drugs. It is important to tailor ART regiments to each person who uses drugs,
taking into consideration underlying medical conditions, side-effects, toxicities, and interactions
between pharmacotherapies for drug abuse treatment (e.g., methadone, etc.) and ART.1 
Evidence has shown that adherence to ARVs among PWUD is possible and probable if specific
approaches are implemented such as:
 Facilitating access to HIV care and treatment clinics (e.g. extended hours, mobile clinic)
 Providing substitution therapy and access to sterile injection equipment on-site with HIV
treatment41 
The primary health care needs of HIV-positive PWUD needs to be addressed, as there is a higher
death rate among HIV-infected persons from non-HIV causes such as pneumonia, liver disease, 
overdose, and suicide.36 Special considerations need to be made to the particular primary health
care needs of PWUD that impact HIV care and treatment, such as endocarditis.  It may also be 
important to address the psycho-social needs of PWUD in particular to cope with the dual stigma
of being a drug user and person living with HIV/AIDS. It is important to systematically manage 
PWUD and are HIV positive by:
1.	 Conducting an initial evaluation in which a complete medical, psychological, and drug-
use history are taken;
2.	 Providing appropriate diagnosis of drug use disorder, which includes conducting a 
thorough assessment of previous and current drug use and treatment;
3.	 Evaluating the HIV/AIDS situation, which is the same evaluation process for non-drug 
users, including a physical examination, CD4 count, and assessment for co-infections and 
co-morbidities; and
4.	 Providing a treatment plan, which depends on the individual needs and may include 
drug treatment, provision of ARVs, treatment/management of co-infections, and
psychosocial treatment.43 
Unfortunately, even when treatment is available, PWUD often fail to access health care for fear of
criminalization and stigmatization.37 In Eastern Europe and Central Asia, only 24% of HIV-positive 
PWID access HIV care and treatment.38 To reduce barriers to access and improve coordination of
the multiple services needed by PWUD, it is essential to link services. Service linkage connects 
HIV care and treatment, primary health care, drug treatment, and psycho-social support services,
which can be accomplished through a variety of service delivery models described in Chapter 4 
(e.g., program collaboration, co-location, and service integration).
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In summary, it is important to address the various health issues affecting people who use drugs
by providing an integrated service delivery model that links HIV care and treatment, drug 
treatment, and primary health care. Also, services should be tailored to the unique condition of
PWUD to ensure ARV adherence and effective care. The tools and resources below provide 
detailed information on HIV care and treatment among drug users.
Tools and Resources: HIV Care and Treatment among Drug Users
Tool 5.7.1 Aceijas, Oppenheimer, Stimson, Ashcroft, Matic, and Hickman (2006): Antiretroviral
treatment for injecting drug users in developing and transitional countries 1 year before the end of
the ‘Treating 3 million by 2005. Making it happen. The WHO strategy’ (‘3by5’)
Tool 5.7.2 ASEAN/USAID/WHO/FHI (2007): Treatment and care for HIV-positive Injecting Drug
Users
Tool 5.7.3 Ball, Weiler, Beg, and Doupe (2005): Evidence for Action: A critical tool for guiding 
policies and programmes for HIV prevention, treatment and care among injecting drug users
Tool 5.7.4 Lert and Kazatchkine (2007): Antiretroviral HIV treatment and care for injecting drug 
users: An evidence-based overview
Tool 5.7.5 NYS DoH AIDS Institute (2009): HIV Clinical Guidelines
Tool 5.7.6 Open Society Institute/International Harm Reduction Development (2004): Breaking 
Down Barriers: Lessons on Providing HIV Treatment to Injection Drug Users
Tool 5.7.7 WHO (2007): HIV/AIDS Treatment and Care for IDUs: Clinical Protocol for WHO
European Region 
Tool 5.7.8 WHO (2006): Basic Principles for Treatment and Psychosocial Support of Drug 
Dependent People Living with HIV/AIDS
Tool 5.7.9 WHO (2006): Treatment of injecting drug users with HIV/AIDS: promoting access and 
optimizing service delivery
Tool 5.7.10 WHO/UNAIDS/UNODC (2005): Policy Brief: Antiretroviral Therapy and Injecting Drug 
Users 
5.8 Treatment for Drug Use and Dependence
Drug treatment is a crucial component of comprehensive HIV prevention, treatment, and care
programs for PWUD. Drug treatment impacts HIV prevention by reducing injection drug use,
sharing of injection equipment, HIV-related sexual risk behavior, and increasing adherence to
ART.39 The goal of such programs is to enable drug users to reduce, then stop drug use to 
minimize the psychological, social, physical, and behavioral problems caused by drug use and to 
prevent relapse.40 It is important to note that there is no single model of drug treatment for all drug
users. Instead, effective treatment programs focus on the multiple needs of the individual by
developing individual-specific treatment plans.
The following should provide basic information on keys steps in assessing and providing
treatment for drug use and abuse.
Assessment of Drug Use and Drug Dependence
A crucial, initial step in the care and treatment of a person who uses drugs is the screening of
current and past drug use and associated risk behaviors. Numerous tools exist (e.g., WHO
Alcohol, Smoking and Substance Involvement Screening Test) to assess drug use and they
should be adapted to and validated with the local drug-using population.
   
 
      
      
   
      
     
   
 
 
   
 
   
     
 
   
    
     
 
 
   
   
  
    
 
  
   
 
 
 
    
     
   
 
  
 
   
   
   
    
 
  
 
   
 
     
  
   
   
 
  
   
Drug Use and Dependence Treatment
Once trained personnel assess drug use and/or dependence, it is important to provide treatment
options. Two modalities of treatment exist for drug use and dependence: pharmacotherapy
programs and behavioral interventions. Evidence suggests that behavioral interventions, coupled
with pharmacotherapy programs, reduce drug use and HIV risk behaviors.48 Part of both
modalities is ensuring activities exist to cope with drug withdrawal, develop skills to decrease and,
if possible, eliminate drug use and HIV/STI risk behaviors, promote life skills for healthier living
and develop skills to prevent, and cope with relapse.41 
I: Pharmacotherapy Programs
The first treatment modality is pharmacotherapy, in which medically supervised prescription drugs
are administered to opioid drug users that either mimic or block the effect of the opioid.
Agonist pharmacotherapy programs provide prescription drugs that mimic the effects of the drug 
being abused.50 Agonist drugs are used for detoxification and during long-term drug dependence
treatment programs. Agonist drugs currently used for drug treatment include methadone and
buprenorphine/suboxone. 
1.	 Detoxification: Agonist medications are used to suppress withdrawal symptoms during
detoxification. Medication is provided over a short period of time with the goal of
eliminating all drugs from the individual’s body prior to beginning a behavioral drug 
treatment program. Note though, that detoxification is not treatment itself, but the first
component of the treatment process. Research has shown that patients who only receive 
medically assisted detoxification during their withdrawal and do not continue with other
components of therapy (i.e., behavioral interventions), eventually relapse and return to
similar patterns of drug abuse as those who were never treated or participated in 
detoxification.42 
2.	 Substitution or maintenance programs: Agonist medications are provided in higher doses
for longer periods of time (6 months or more), allowing the individual time to reduce their
risk behaviors and stabilize themselves in health and social terms before facing withdrawal
symptoms.43 Substitution/maintenance programs are associated with significant decrease
in injection drug use and sharing injection equipment as well as associated with a 
decrease in the number of sexual partners, exchanges of sex for drugs or money, and
increased compliance with ARTs.53 
Antagonist pharmacotherapy programs provide prescription drugs that block the desired effect of
the opioid. Presently, the only antagonist available is naltrexone, which provides low levels of side 
effects but the uptake and retention of this treatment by people who use drugs has been poor.53 
Patients who are highly motivated and have supportive social environments are most likely to 
benefit from naltrexone treatment and remain drug-free.51 
II: Behavioural Interventions to Reduce Drug Use and Related HIV/STI Risk Behaviors
Behavioural interventions aim to decrease drug use and associated health risk by working with 
the drug user to change his/her behaviour through manageable, incremental changes.
Behavioural interventions include a variety of approaches such as counselling, behavioural
therapy, brief behavioural interventions/brief motivational interviewing, self-help programs (i.e.,
alcoholics anonymous and narcotics anonymous), residential/therapeutic community programs,
and abstinence-based programs. These interventions include activities to support lifestyle 
adjustments, such as reducing drug and alcohol use and HIV/STI risk behaviours and enhancing 
skills to reduce relapse.64 Behavioural interventions can be delivered through HIV prevention 
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activities/outreach in health care settings or in dedicated outpatient or residential drug treatment
facilities.
Further information on drug use and dependence treatment is provided in the tools and resources
below.
Tools and Resources: Treatment for Drug Use and Dependence
Tool 5.8.1 Center for Strategic and International Studies (2008): Combating the Twin Epidemics of 
HIV/AIDS and Drug Addiction 
Tool 5.8.2 Chawarski, Barry, Mazlan, and Schottenfeld (2006): Behavioral Drug and HIV Risk 
Counseling for Opioid Dependent Individuals   
Tool 5.8.3 Drug Policy Alliance (2003): About Methadone 
Tool 5.8.4 Farrell, Gowing, Marsden, Ling, and Ali (2005): Effectiveness of drug dependence 
treatment in HIV prevention 
Tool 5.8.5 Mattick, Kimber, J, Breen & Davoli (2003): Buprenorphine maintenance versus placebo 
for methadone maintenance for opioid dependence. 
Tool 5.8.6 NIDA (2009): Principles of Drug Addiction Treatment: A Research-Based Guide 
Tool 5.8.7 NIDA (2009): Treatment Approaches for Drug Addition 
Tool 5.8.8 NIDA (2006): Methadone Research Web Guide  
Tool 5.8.9 NYODH AIDS Institute (2009): HIV Clinical Guidelines: Substance Use Treatment 
Modalities for HIV-infected Persons 
Tool 5.8.10 NYODH AIDS Insitute (2007): HIV Clinical Guidelines: Screening and Ongoing 
Assessment for Substance Use 
Tool 5.8.11 SAMHSA (2010): Treatment Improvement Protocol  
Tool 5.8.12 SAMHSA (2007): Buprenorphine: A Guide for Pharmacists  
Tool 5.8.13 UNODC (2009):  Principles of Drug Dependence Treatment, Discussion paper.   
Tool 5.8.14 UNODC (2004): Substance abuse treatment and care for women: Case studies and 
lessons learned 
Tool 5.8.15 UNODC (2003): Drug Abuse Treatment and Rehabilitation: A Practical Planning and 
Implementation Guide 
Tool 5.8.16 WHO (2009): Guidelines for the psychosocially assisted pharmacological treatment of 
opioid dependence   
Tool 5.8.17WHO (2005): Evidence for Action: Effectiveness of Drug Dependence Treatment in 
Preventing HIV among Injection Drug Users   
Tool 5.8.18 WHO (2004): Policy Brief: Reduction of HIV Transmission through Drug-Dependence 
Treatment  
Tool 5.8.19 WHO (2004): The Practices and Context of Pharmacotherapy of Opiod Dependence in 
Central and Eastern Europe 
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Tool 5.8.20 WHO (2003): The Alcohol, Smoking and Substance Involvement Screening Test
(ASSIST): Guidelines for Use in Primary Care, Draft
Tool 5.8.21 WHO (2003): Brief Intervention for Substance Use: A Manual for use in Primary Care,
Draft 
Tool 5.8.22 WHO (2003): Self-Help Strategies for Cutting Down or Stopping Substance Use: A
Guide, Draft 
Tool 5.8.23 WHO/UNODC/UNAIDS (2004): Substitution maintenance therapy in the management
of opiod dependence and HIV/AIDS prevention 
5.9 Prevention, Diagnosis and Treatment of Tuberculosis
Tuberculosis (TB) is a contagious, bacterial disease caused by Mycobacterium tuberculosis
transmitted through airborne, infectious particles from person-to-person. A person can be infected 
with TB (latent TB) without developing TB disease (active TB), a state in which one or more 
organs of the body become diseased. The progression of latent TB to TB disease (active TB) is
most likely during the first year of TB infection and in individuals who are HIV positive due to a 
weakened immune system. HIV-positive individuals who are infected with TB have a 5–10%
annual risk of progressing to TB disease as opposed to TB-infected, HIV-negative individuals who 
have a 5–10% lifetime risk of progressing to TB disease.44 Tuberculosis is a leading cause of
mortality among HIV-positive people who inject drugs.45 
However, injection drug use is associated with increased rates of TB infection and disease,
regardless of HIV status. PWUD experience other numerous other risk factors for TB disease
such as incarceration, poor living conditions, and poverty.55 
The World Health Organization developed a set of recommendations for TB control in PWUD,
which includes:
•	 TB prevention though the implementation of an infection control plan and simple measures
to reduce TB transmission (i.e. natural ventilation, air cleaners, etc), separating people 
suspected of having TB, diagnosing and starting TB treatment quickly
•	 Implementation of HIV prevention interventions for PWUD (community outreach, access to
and safe disposal of injection equipment, risk reduction counseling, etc)
•	 Intensified case-finding, diagnosis of TB and testing for HIV to identify/manage TB and
HIV early which can reduce transmission and improve health outcomes
•	 TB treatment through provision of direct observed therapy (DOTS)
•	 HIV care and treatment for HIV positive PWUD
•	 Identification of drug use and referral to treatment programs55 
The following tools and resources provide in-depth discussions of TB prevention, diagnosis, and
treatment among PWUD.
Tools and Resources: Prevention, Diagnosis and Treatment of TB
Tool 5.9.1 WHO (2008): Evidence for Actions: Policy Guidelines for Collaborative TB and HIV
Services for Injecting and Other Drug Users: An Integrated Approach 
Tool 5.9.2 WHO (2008): Policy Brief: Policy Guidelines for Collaborative TB and HIV Services for
Injecting and Other Drug Users
Tool 5.9.3 WHO (2004): TB/HIV: A Clinical Manual
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5.10 Vaccination, Diagnosis, and Treatment of Viral Hepatitis 
PWUD are at increased risk for other blood-borne pathogens, such as viral hepatitis, due to 
sharing of injection equipment and higher frequency of unprotected sex. Viral hepatitis is an
inflammation of the liver caused by Hepatitis A, B, C, D, and E viruses. Among PWUD, Hepatitis
B and C are most common.1 
Hepatitis B Virus (HBV) can be transmitted from mother to child during labor and delivery, through 
unsafe injection practices, sharing of contaminated drugs, needles, or other injecting equipment,
blood transfusions, and unprotected sex.46 HBV is transmitted by the same route as HIV but is 50
to 100 times more infectious and can survive outside the body for at least 7 days and still cause 
infection.56 Hepatitis C Virus (HCV) is primarily transmitted through contact with the blood of an
infected person, which includes blood transfusions with infected blood, sharing of contaminated
injection equipment, through accidental needle sticks or sharps exposure, and to a lesser extent,
through unprotected sex and from infected mother to child.56 People who use drugs are at
increased risk for HBV and HCV given the frequency of unsafe injecting practices and
unprotected sex.
HBV and HCV can be both acute and chronic. Acute Hepatitis is a short-term illness that occurs
within the first 6 months of exposure to the virus. Chronic Hepatitis occurs in some but not all
exposed individuals and can lead to liver cirrhosis and liver cancer. 1 
Hepatitis B can be prevented by vaccination. According to the WHO, PWID who are not infected 
with HBV should be vaccinated with the Hepatitis B vaccine.56 Vaccination against HBV is 95%
effective in preventing HBV and its chronic consequences. For persons with acute HBV there is
no specific treatment, but persons with chronic HBV can be treated with drugs including interferon 
and antiviral agents. Currently, there is no vaccination for Hepatitis C. According to CDC,
individuals with acute HCV can be provided with antivirals and supportive treatment and
individuals with chronic HCV should be monitored regularly for signs of liver disease and may be 
treated with antivirals.47 
Special attention needs to be paid to HIV-positive PWUD who are co-infected with HBV and/or
HCV to ensure treatment of both viral hepatitis and HIV are effective and appropriate for the 
individual.
The following tools and references provide in-depth discussion of the Hepatitis B and C among 
PWUD.
Tools and Resources: Vaccination, Diagnosis and Treatment of Viral Hepatitis
Tool 5.10.1 AED/CDC (2002): Viral Hepatitis and Injection Drug Users
Tool 5.10.2 IOM (2010): Hepatitis and Liver Cancer: A National Strategy for Prevention and Control
of Hepatitis B and C
Tool 5.10.3 New York Department of Health AIDS Institute (2009): HIV and Substance Use Clinical
Guidelines: Aspects of Primary Care for the HIV-Infected Substance User
Tool 5.10.4 WHO/SERO (2009): Management of common health problems of drug users 
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CHAPTER 6: IMPLEMENTING HIV INTERVENTIONS AMONG
INCARCERATED PEOPLE WHO USE DRUGS 
Globally, there are more than 9.8 million people incarcerated (145 per 100,000).48 In most
countries, prevalence of HIV infection among this population is much higher than in non-
incarcerated populations as shown below.49 
Comparison of HIV Prevalence in Prison Populations and General Population59 
Country HIV prevalence  
(% adults 15–49)
Prison Population 
(in thousands)
HIV prevalence among 
prisoners (% and year)
Cote d’Ivoire 7 10,355 28  (1993)
Senegal 0.9 22,271 2.7 (1997)
Burkina Faso 2 2,800 11  (1999)
Nigeria 4 40,444 9  (2004)
Cameroon 5.4 20,000 12  (2005)
Rwanda 3 112,000 13  (1993)
Tanzania 6.5 46,410 5.6 (1995)
Uganda 6.7 21,900 8  (2002)
South Africa 18.8 186,739 45  (2006)
Malawi 14 8,769 75  (N/A)
Zambia 17 13,200 27  (1999)
Most incarcerated persons contract HIV outside of prisons and other closed settings by engaging
in high-risk activities that are criminalized such as injection drug use. Transmission of HIV within
incarcerated settings occurs primarily through unsafe (e.g., sharing and improper cleaning)
injecting practices, unsafe sex (e.g., unprotected anal sex and sexual violence), and to a lesser
extent, unsafe tattooing/body piercing.50 To reduce the harm from unsafe drug and sex-related 
risk behaviors, interventions need to be implemented in closed settings to reduce transmission 
and acquisition of HIV and other blood-borne pathogens.60 
To address drug use, especially injection drug use during incarceration, a comprehensive 
HIV/AIDS program needs to be considered, which includes: 
1.	 HIV/AIDS education
2.	 HIV testing and counseling that is easily accessible and confidential.
3.	 Prevention of sexual transmission including distribution of condoms and water-based
lubricants and post-exposure prophylaxis for victims of sexual violence.
4.	 STI screening and management through regular screening and treatment coupled with 
presumptive treatment when needed.
5.	 Access to and Safe Disposal of Injection Equipment including access to sterile
injecting equipment, education, and supplies to decontaminate and/or dispose of used
injecting equipment.
6.	 Measures to reduce demand for and supply of drugs in prisons including monitoring 
drug use through urinalysis and creating “drug-free” environments to discourage drug use.
7.	 HIV care and treatment equivalent to services outside incarceration settings and 

continuity of care when the prisoner returns to the community.
 
8.	 Drug treatment that combines pharmacotherapy and behavioral interventions that
 
continues outside of incarceration.60
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PWUD should be linked to HIV and drug treatment services upon release from incarceration.  
This ensures continuity of care for incarcerated populations as they reintegrate back into society.
Further information on drug use and HIV in prisons is provided in the tools and resources listed 
below.
Tools and Resources: Implementing HIV Interventions among Incarcerated People who use
Drugs
Tool 6.1 Canadian HIV/AIDS Legal Network (2006): Prison Needle Exchange: Lessons from a 
Comprehensive Review of International Evidence and Experience 
Tool 6.2 SAMHSA (2005): Treatment Improvement Protocol 44: Substance Abuse Treatment for 
Adults in Criminal Justice System 
Tool 6.3 SAMHSA (2002): Substance Abuse Treatment for Women Offenders: Guide to Promising 
Practices 
Tool 6.4 UNODC (2007): HIV/AIDS in places of detention: A toolkit for policy makers, managers, 
and staff 
Tool 6.5 UNODC (2007): Preventing Drug Use and HIV among Incarcerated Substance Users: 
Module for Prison Intervention  
Tool 6.6 UNODC (2006): HIV/AIDS Prevention, Care, Treatment, and Support in Prison Settings 
Tool 6.7 UNODC/UNAIDS (2008): Women and HIV in Prison Settings 
Tool 6.8 UNODC, UNAIDS, World Bank (2007): HIV and Prisons in sub-Saharan Africa: 
Opportunities for Action    
Tool 6.9 WHO (2007): Effectiveness of interventions to address HIV in prisons 
Tool 6.10 WHO (2007): Interventions to Address HIV in Prisons: Drug Dependence  
Treatments 
Tool 6.11 WHO (2007): Interventions to Address HIV in Prisons: HIV Care, Treatment and Support 
Tool 6.12 WHO (2007) Interventions to Address HIV in Prisons: Needle and Syringe Exchange 
Programmes and Decontamination Strategies 
Tool 6.13 WHO (2007) Interventions to Address HIV in Prisons: Prevention of Sexual Transmission 
Tool 6.14 WHO (2007): Inside Out: HIV Harm Reduction Education for Closed Settings  
Tool 6.15 WHO (2004): Policy Brief: Reduction of HIV Transmission in Prisons 
Tool 6.16 Williams and Kahn (2007): Looking Inside and Affecting the Outside: Corrections-Based 
Interventions for STD Prevention 
   
    
 
 
   
     
 
    
 
   
   
   
 
  
  
  
     
  
  
   
 
 
        
   
       
     
     
  
  
 
  
  
  
 
  
      
 
 
  
      
    
   
     
     
 
 
      
        
  
 
     
 
     
CHAPTER 7: MONITORING AND EVALUATING HIV INTERVENTIONS
AMONG PEOPLE WHO USE DRUGS
Monitoring and evaluating (M&E) interventions is critical in understanding the benefits and
barriers of HIV prevention among drug-using populations. The information from M&E programs
also assists in advocacy, highlights key issues, and provides stakeholder and donors information 
on their investment. Monitoring and evaluation is used to answer the following questions:
1.	 Are we doing the right thing?
2.	 Are we doing it right?
3.	 Are we doing it on a large enough scale?58
Effective M&E of a program/project starts with the setting of specific goals, objectives, strategies,
and measurable targets with clear timelines for their achievement during program planning. Clear
targets form a benchmark against which to measure performance and are used to inform program
planning and modifications. Monitoring is the routine collection of data to assess the progress of
the program and evaluation measures how well the program achieves their objective. M&E
includes process monitoring and evaluation, measuring uptake, and coverage and outcome 
evaluation.
Process monitoring and evaluation
Process monitoring (i.e., monitoring) occurs from the inception of the program with routine data
collection to assess the services being offered and activities conducted (e.g., number of products
distributed and number of outreach events carried out) throughout the life of the program.61 
Routinely collected data needs to be analyzed regularly to provide current information on the 
progress of the program and feedback to the program staff who will institute any adaptations
needed to the program based on the data. Process monitoring should be integrated into the 
routine function of program management.61 
Process evaluation (output evaluation) occurs once the activities are implemented and is used to 
determine whether the activities are being implemented correctly and efficiently. Process
evaluation addresses two questions:
1.	 To what extent are planned intervention activities actually realized?
2.	 What services are provided, to whom, when, how often, for how long, and in what
 
context?61
 
Process evaluation often occurs in strategic intervals during the program to provide descriptive 
data. If the program is not achieving the desired results, utilizing process evaluation allows
managers and stakeholders to change the direction of the program to more effectively meet the 
objectives. To determine program implementation quality, process evaluation may utilize a variety
of data collection activities, such as client and staff interviews, observation, facility audits,
interviews with complementary service providers, and focus group interviews.61
Uptake and Coverage
Uptake measures the amount of, and degree to which, the program services are used.  Coverage
measures whether the program is targeting the appropriate areas and is reaching the target
population. Coverage answers the following questions:
1.	 Are services available for people who use drugs in the areas where this population is
concentrated?
2.	 Are sufficient numbers of the targeted population actually receiving services?
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 32
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Coverage is determined by the proportion of the target population reached with services. To 
effectively measure coverage, program staff will need to map locations where drug use occurs
and PWUD congregate as well as determine the size of the population in a defined area. Once 
the size and location of PWUD is identified, services should be implemented. It is not only
important to saturate an area with services (coverage) but it is equally important that PWUD use
the services (uptake). This will provide information on the program’s ability to reach and be 
accepted by the target population.61 
Outcome Evaluation
Outcome evaluation occurs periodically throughout the program to determine whether, and by
how much, program activities achieve their intended effects on the target population. Outcome
evaluation answers two key questions:
1. Does the program result in the desired outcomes within the target population?
2. Are these outcomes attributable to the program?61 
By answering these questions, the evaluation shows the outcomes that are attributable to the 
intervention and if the intervention was successful in meeting the program objectives.
Listed below are examples of possible indicators for HIV prevention programs among PWUD.59–61
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Selected Monitoring and Evaluation Indicators: Drug Use and HIV/AIDS
Indicator Label Source Type Level
Percentage of drug users who are HIV infected UNGASS Impact National
COMMUNITY OUTREACH
Number of drug users reached through community outreach programs UNGASS Monitoring Program
Number of referrals made (HTC, STI, HIV, and drug treatment, etc.) UNGASS Monitoring Program
CONDOM USE
Percentage of IDUs reporting the use of condom at last sex act UNGASS Outcome National
Number of condoms or lubricants distributed UNGASS Monitoring Program
Percentage of DUs (injecting and non-injecting, by sex) using condoms
the last time they had sex for money or drugs CDC Outcome National
KNOWLEDGE/BEHAVIOR CHANGE
Percentage of DUs who both correctly identify ways of preventing the 
sexual transmission of HIV and who reject major HIV misconceptions UNGASS Outcome National
Percent of IDUs reached by IEC WHO Coverage Program
Number of IDUs reached with individual and/or small group level
interventions that are based on evidence and/or meet the minimum
standards required
PEPFAR Mentoring Program
HIV TESTING AND COUNSELING
Percentage of DUs who received an HIV test in the last 12 months and
know their status UNGASS Coverage National
Number of HIV+ IDUs unaware of HIV status reduced WHO Outcome National
Number of sites with VCT for IDUs WHO Monitoring Program
Number of DUs tested for HIV UNGASS Monitoring Program
SAFE INJECTING PRACTICES
Percentage of IDUs reporting the use of sterile injection equipment the 
last time they injected UNGASS Outcome National
Percentage of IDUs reached by NSE programs WHO Coverage National
Number of syringes distributed per IDU WHO Monitoring Program
STI PREVENTION AND TREATMENT FOR DRUGS USERS
Percentage of IDUs screened and treated for STIs WHO Coverage National
Reduction in numbers of STIs in IDUs WHO Impact National
ANTIRETROVIRAL THERAPY (ART)
Percentage of IDUs receiving ART WHO Coverage National
Decreased mortality, AIDS cases, and HIV incidence in IDUs WHO Impact National
DRUG TREATMENT
Number of IDUs on opioid substitution therapy PEPFAR Monitoring National
Percentage of IDUs on opioid substitution therapy WHO/PEPFAR Coverage National
Number of opioid substation therapy sites WHO Monitoring Program
Percentage of IDus in other drug treatment programs WHO Coverage National
Reduction in frequency of injections among IDUs WHO Outcome National
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 34
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The following documents provide detailed information on measuring progress in HIV prevention 
among most-at-risk populations which include drug users.
Tools and Resources: Measuring Progress and Evaluating HIV Interventions among Drug-
Using Populations
Tool 7.1 CDC (2004): Monitoring & Evaluation Capacity Building for Program Improvement Field
Guide
Tool 7.2 UNAIDS (2007): A Framework for Monitoring and Evaluating HIV Prevention Programmes
for Most-At-Risk Populations
Tool 7.3 WHO/UNAIDS (2004): Guidelines for Effective Use of Data from Surveillance Systems
Tool 7.4 WHO/UNODC/UNAIDS (2008): Technical Guide for Countries to set Targets for Universal
Access to HIV Prevention, Treatment, and Care for Injecting Drug Users (IDUs)
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CHAPTER 8: ADVOCACY AND POLICY FOR HIV INTERVENTIONS
AMONG PEOPLE WHO USE DRUGS
Specific policies should be developed at varying levels (community, state, and national) to provide
guidance on HIV/AIDS prevention, care and treatment for PWUD. HIV and drug use policy needs
to be developed in conjunction with continuous advocacy efforts to ensure decision makers are 
effectively and appropriately targeting policies and programs towards drug-using populations.
Both advocacy and policy efforts should include PWUD in the planning and implementation of
activities. Policy development should be focused on decreasing the HIV/AIDS burden among
PWUD and may include the following:
 Developing and implementing comprehensive and multi-component HIV programs;
 Targeting HIV prevention activities specifically towards PWUD;
 Integration of HIV prevention and care;
 Creating an enabling environment;
 Integrating major policies and strategies (e.g., HIV/AIDS strategy with drug strategy);
 Assessing the environmental and structural context of drug use (e.g., poverty and
 
unemployment); and
 
 Creating links between drug treatment and HIV treatment.61 
It is crucial that the policy environment within a country or region enable drug users to access
health care. To create these policies, it is important to integrate prevention and care initiatives,
provide comprehensive health education, change and/or amend drug laws, and lobby for national
and political support.64 
Advocacy efforts should aim to protect the human and legal rights of drug users, reduce stigma
and discrimination, and provide HIV/AIDS services to this population.51 Advocacy usually begins
with a concerned group of citizens who develop proposals and build support to change current
practices such as decreasing barriers for PWUD to access health care. Advocacy efforts should 
promote:
 Protection of the human rights of PWUD
 Early implementation of HIV prevention programs
 Evidence-based, comprehensive package of services with regular assessment and 

improvement as needed
 
 Universal coverage of services for both PWUD and PWID65 
It is important that stakeholders and target population members are involved in both advocacy
and policy development and implementation to ensure success.
The following documents discuss in greater detail the principles, strategies, and components of
advocacy and policy development for HIV/AIDS programs targeted towards PWUD.
Tools and Resources: HIV Prevention among Drug-Using Populations Advocacy and Policy
Tool 8.1 UNAIDS (2006): International Guidelines on HIV/AIDS and Human Rights
Tool 8.2 WHO (2004): Policy and Programming Guide for HIV/AIDS Prevention and Care among 
Drug Users
Tool 8.3 WHO/UNAIDS/UNODC (2006): Advocacy Guide: HIV/AIDS Prevention among IDUs
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Appendix 1: Annotated List of Tools and Resources
Appendix 2: Additional Web Resources
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 37
   
    
  
   
 
  
   
 
 
  
 
 
   
    
 
  
 
 
      
  
  
  
 
  
   
 
  
    
 
  
 
 
 
 
 
   
  
  
 
 
 
  
    
 
  
   
 
  
 
 
 
   
 
 
 
 
  
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 38
APPENDIX 1: ANNOTATED LIST OF TOOLS
CHAPTER 2: BACKGROUND AND OVERVIEW OF DRUG USE AND HIV
Tool 2.1
Title Global overview of injecting drug use and HIV infection among injecting drug users
Author /
Institution
Carmen Aceijas, Gerry V. Stimson, Matthew Hickman, and Tim Rhodes,
2004
Description
This article provides global estimates of the prevalence of injection drug
use and HIV prevalence among IDU, especially providing estimates for
developing and transitional countries.
Link to Tool http://www.ncbi.nlm.nih.gov/pubmed/15577542
Source /
Contact
Aceijas, C., Stimson, G. V., Hickman, M., & Rhodes, T. (2004). Global
overview of injecting drug use and HIV infection among injecting drug
users. AIDS, 18(17), 2295–2303.
Tool 2.2
Title Drug Use and HIV Curriculum
Author /
Institution Centers for Disease Control and Prevention, 2007
Description This curriculum provides an overview of HIV, IDU/NIDU, and the
relationship between HIV and drug use.
Link to Tool N/A
Source /
Contact
Karen Kroeger, PhD
Global AIDS Program, NCHHSTP, Centers for Disease Control and 
Prevention
1600 Clifton Road, MS – E-04, Atlanta, GA 30333
Tel: 404-639-4488; Fax: 404-639-8114
Email: Knk2@cdc.gov
Web site: www.cdc.gov
Tool 2.3
Title Preventing HIV Infection among Injecting Drug Users  in High RiskCountries: An Assessment of the Evidence
Author /
Institution Institute of Medicine, 2007
Description This document provides a current assessment of evidence on HIV
prevention amongst IDUs.
Link to Tool http://www.nap.edu/catalog/11731.html
Source /
Contact
National Academies Press
500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055
Tel: +1 800 624 6242
Web site: www.iom.edu
   
  
   
 
 
   
    
   
 
 
  
  
  
   
 
   
 
 
   
  
 
 
 
  
    
 
  
 
 
   
 
  
 
 
 
 
 
  
 
 
  
  
 
    
 
    
  
   
   
 
 
  
 
  
  
  
Tool 2.4
Title Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Author /
Institution
Bradley M. Mathers, Louisa Degenhardt, Benjamin Phillips, Lucas
Wiessing, Matthew Hickman, Steffanie A. Strathdee, Alex Wodak,
Samiran Panda, Mark Tyndall, Abdalla Toufik, and Richard P. Mattick,
2008
Description
This article aims to systematically search and critique the peer-reviewed 
and non-peer-reviewed (grey) literature reporting data on the epidemiology
of injecting drug use, provide country-specific estimates derived from the
reviewed literature, and produce regional and global estimates of the
number of people who inject drugs and who may be living with HIV/AIDS.
Link to Tool http://www.who.int/hiv/topics/idu/LancetArticleIDUHIV.pdf
Source /
Contact
Mathers, B., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M.,
Strathdee, S. A.,…Mattick, R. P. (2008). Global epidemiology of injecting
drug use and HIV among people who inject drugs: a systematic review. 
Lancet, 372, 1733–1745.
Tool 2.5
Title Special Issue Substance Abuse and HIV/AIDS in sub-Saharan Africa
Author /
Institution African Journal of Drug and Alcohol Studies, 2006
Description
The papers in this special issue of the journal discuss the links between 
substance abuse and HIV infection based on research conducted in seven 
countries, Kenya, Mauritius, Nigeria, Rwanda, South Africa, Tanzania, and
Zambia.
Link to Tool http://www.sahealthinfo.org/admodule/journal52006.htm
Source /
Contact
African Journal of Drug and Alcohol Studies
CRISA, 10 Sandview Ct., Baltimore, MD 21209 
Tel: +1 410 602 1614
E-mail: isobot@hotmail.com
Tool 2.6
Title World Drug Report
Author /
Institution United Nations Office on Drugs and Crime, 2008
Description
The World Drug Report presents the most comprehensive, statistical view 
of the present illicit drug situation, discusses methods to better assess and 
monitor drug use, and the role played by organized crime in drug trafficking.
Link to 
Tool http://www.unodc.org/documents/wdr/WDR_2008/WDR_2008_eng_web.pdf
Source /
Contact
United Nations Publications
Sales Office and Bookshop 
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027 
E-mail: unpubh@unog.ch
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CHAPTER 3: ASSESSING THE HIV/AIDS EPIDEMIC AMONG DRUG USERS

Tool 3.1
Title
International Rapid Assessment Response and Evaluation (I-RARE)
Methods Training for Field Teams: Using Rapid Assessment
Methodologies and Qualitative Analysis Techniques to Understand 
and Respond to the HIV Epidemic in Drug-Using Populations and 
Analysis Training Curriculum for Data Analysis Teams: Using Rapid
Assessment Methodologies and Qualitative Analysis Techniques to 
Understand and Respond to the HIV Epidemic in Drug-Using 
Populations
Author /
Institution Centers for Disease Control and Prevention, 2007
Description This document provides instruction on the methodology of and
implementing I-RARE.
Link to Tool N/A
Source /
Contact
Karen Kroeger, PhD
Division of STD Prevention, NCHHSTP, Centers for Disease Control and
Prevention
1600 Clifton Road, MS – E-04, Atlanta, GA 30333
Tel: 404-639-4488; Fax: 404-639-8114
Email: Knk2@cdc.gov
Web site: www.cdc.gov
Tool 3.2
Title Special Issue on Respondent Driven Sampling
Author /
Institution
Journal of Urban Health Supplement (Ed. Abu Abdul-Quader, Douglas
Heckathorn, Keith Saban, and Tobi Saidel), 2006
Description
To provide evidence for the progress of RDS in targeting hard to reach
populations, issues with implementing RDS, and discussion the integration 
of RDS sampling into routine surveillance and intervention research.
Link to Tool www.springeronline.com
Source /
Contact
Journal of Urban Health, Office of Publication
233 Spring Street, New York, NY 10013
Tel: +1 212 460 1500
Email: journals-ny@springer.com
Tool 3.3
Title Methods for assessing HIV and HIV risk among IDUs and forevaluating interventions
Author /
Institution
Gerry V. Stimson, Matthew Hickman, Tim Rhodes, Francisco Bastos, and
Tobi Saidel, 2005
Description
This article describes three levels of assessment, basic assessment in
situations with low awareness and information, routine surveillance, and 
enhanced surveillance to assess the HIV and HIV risk among IDUs.
Link to Tool http://linkinghub.elsevier.com/retrieve/pii/S0955395905000836
Source /
Contact
Stimson, G. V., Hickman, M., Rhodes, T., Bastos, F., & Saidel, T. (2005).
Methods for assessing HIV and HIV risk among IDUs and for evaluating 
interventions. International Journal of Drug Policy, 16S, S7–S20.
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Tool 3.4
Title Guidelines on Estimating the Size of Populations Most at Risk to HIV
Author /
Institution
United Nations Joint Commission on HIV/AIDS and World Health
Organization Working Group On Global HIV/AIDS and STI Surveillance, 
2010
Description This document provides guidance on establishing the size of populations
most-at-risk to HIV to measure and understand these populations.
Link to Tool http://www.who.int/hiv/pub/surveillance/final_estimating_populations_en.pdf
Source /
Contact
UNAIDS Information Centre 
20 Avenue Appia, 1211 Geneva 27 Switzerland 
Tel: +41 22 791 36 66; Fax: +41 22 791 48 35
E-mail: distribution@unaids.org
Web site: www.unaids.org
Tool 3.5
Title Estimating the Size of Populations at Risk for HIV
Author /
Institution
United Nations Joint Programme on HIV/AIDS, IMPACT, and Family Health 
International, 2003
Description
This document provides guidelines for estimating the size of
subpopulations where risk behaviors are causing the HIV epidemic; (Latin
American, Eastern Europe, and Asia specifically mentioned) and presents
methods and issues for measuring these populations.
Link to Tool http://www.fhi.org/en/HIVAIDS/pub/guide/popsizecontent.htm
Source /
Contact
Publications Coordinator
Family Health International
P.O. Box 13950, Research Triangle Park, NC 27709 USA.
Tel: +1 919 544 7040; Fax: +1 919 544 7261
Tool 3.6
Title Rapid Assessment of Alcohol and Other Substance Use in Conflict-affected and Displaced Populations: A Field Guide
Author /
Institution United Nations High Commission on Refugees, 2008
Description
This guide provides operational guidance to agencies working with conflict-
affected and displaced populations in recognizing and assessing the public
health and social impact associated with alcohol and other substance use.
Link to 
Tool www.who.int/mental_health/emergencies/unhcr_alc_rapid_assessment.pdf
Source /
Contact
United Nations High Commissioner for Refugees
Public Health and HIV Section
CP 2500, 1202 Geneva, Switzerland
Tel: +1 41 22 739 8111
Email: hivaids@unhcr.org
Web site: http://www.unhcr.org/hivaids
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Tool 3.7
Title Developing an Integrated Drug Information System: GlobalAssessment Programme on Drug Abuse
Author /
Institution United Nations Office on Drug and Crime, 2003
Description
This series of eight modules assists Member States in developing capacity
to monitor patterns and trends in drug abuse and reducing negative health
and social consequences of drug abuse.
Link to Tool http://www.unodc.org/documents/GAP/GAP%20toolkit%20module%201%
20final%20ENGLISH_E-book.pdf
Source /
Contact
United Nations Publications, Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027
Web site: www.unodc.org
Tool 3.8
Title Rapid Assessment and Response Guide on Psychoactive Substance Use and Sexual Risk Behaviour
Author /
Institution World Health Organization, 2003
Description
This guide describes how to use RAR to both profile local substance use
and sexual risk behavior and to identify appropriate intervention responses
in time and resource constrained settings.
Link to Tool http://www.who.int/substance_abuse/publications/epidemiology/en/index.ht 
ml
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 731 4857
Email: bookorders@who.int
Web site: http://www.who.int/en/
Tool 3.9
Title Rapid Assessment and Response Guide on Injection Drug Use (IDU-RAR)
Author /
Institution World Health Organization, 1998
Description
This document provides a guide on conducting a rapid assessment and
response to facilitate the reduction of adverse health consequences of
injection drug use.
Link to Tool https://www.unodc.org/documents/hiv-
aids/IDU%20rapid%20ass.%20and%20resp.%20guide.pdf
Source /
Contact
The Centre for Research on Drugs and Health Behaviour,
200 Seagrave Road, London, SW6 1RQ, United Kingdom
Tel: +44 181 846 6557; Fax: +44 181 846 6505
Email g.stimson@ic.ac.uk
Web site: http://www.who.int/en/
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CHAPTER 4: PLANNING HIV PREVENTION INTERVENTIONS AND PROGRAMS AND 
PROGRAMS FOR PEOPLE WHO USE DRUGS
Tool 4.1
Title A Comprehensive Approach: Preventing Blood-Borne Infectionsamong Injection Drug Users
Author /
Institution
Academy for Educational Development/Centers for Disease Control and
Prevention, 2000
Description
This technical assistance guide describes eight complementary strategies
that detail the need for, and describe the characteristics of, this 
comprehensive approach for preventing HIV and other blood-borne
infection among IDUs.
Link to Tool http://www.cdc.gov/idu/pubs/ca/comprehensive-approach.pdf
Source /
Contact
Centers for Disease Control and Prevention
1600 Clifton Road, MS – E-04, Atlanta, GA 30333
CDC Tel: +1 404 639 5230; AED Tel: +1 202 884 8952.
Web site: http://www.cdc.gov/idu
Tool 4.2
Title Manual for Reducing Drug Related Harm in Asia
Author /
Institution Center for Harm Reduction, 2003
Description
This manual contains the accumulated experience of over a decade of
attempts to change policy and implement programs for harm reduction in 
Asia and provides guidance for advocacy and design of programs to
reduce HIV-related harm among drug users in Asia.
Link to Tool www.who.int/hiv/topics/harm/manual2003.pdf
Source /
Contact
The Centre for Harm Reduction
The Macfarlane Burnet Institute for Medical Research & Public Health Ltd.
Commercial Road, Melbourne Victoria, 3004, Australia
P.O. Box 2284, Melbourne Vic, 3001, Australia
Tel: +161 3 9282 2169; Fax: +61 3 9482 3123
Email: crofts@burnet.edu.au
Web site: http://www.burnet.edu.au/home
Tool 4.3
Title HIV/AIDS Prevention and Care in Resource-Constrained Settings: AHandbook for the Design and Management of Programs
Author /
Institution Family Health International, 2001
Description This handbook guides programs in developing effective HIV/AIDS
programs in resource-constrained settings.
Link to Tool http://www.fhi.org/en/HIVAIDS/pub/guide/HIVAIDSPreventionCare.htm
Source /
Contact
Family Health International, FHI AIDS Institute
2101 Wilson Boulevard, Arlington, VA 22201
Tel: +1 703 516 9779; Fax: +1 703 516 9781
Web site: http://www.fhi.org 
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Tool 4.4
Title Targeted Interventions under NACP III: Operational Guidelines
Author /
Institution National AIDS Control Organization: Government of India, 2007
Description
These guidelines describe the operational details of targeted intervention 
projects with various core, high-risk groups (female sex workers, men who 
have sex with men, transgenders, and injecting drug users) as well as
discuss issues related to program management, human resources,
infrastructure, linkages, and monitoring and evaluation.
Link to Tool http://www.nacoonline.org/Quick_Links/Publication/
Source /
Contact
National AIDS Control Organization, Ministry of Health & Family Welfare
Government of India
9th Floor, Chandralok Building, 36 Janpath, New Delhi, 110001
Tel: +1 23325331; Fax: +1 23731746
Tool 4.5
Title Principles of HIV prevention in drug-using populations: A research-based guide
Author /
Institution National Institute on Drug Abuse, 2002
Description This research-based guide summarizes basic HIV principles among drug 
users and describes the epidemiology of HIV/AIDS risk behaviors.
Link to Tool http://www.drugabuse.gov/pohp/research.html
Source /
Contact
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard, Room 5213
Bethesda, MD 20892-9561
Tel: + 1 877 643 2644; Fax: + 1-240-645-0227
Email: drugpubs@nida.nih.gov
Web site: www.drugabuse.gov
Tool 4.6
Title HIV and Substance Use Clinical Guidelines: Working with the Active User
Author /
Institution New York Department of Health AIDS Institute, 2009
Description
Provides guidance on working with active drug users, including 
recommendations on service delivery models and types of interventions to
be offered.
Link to Tool http://www.hivguidelines.org/clinical-guidelines/hiv-and-substance-
use/working-with-the-active-user/
Source /
Contact
NYDOH AIDS Institute Office of the Medical Director
90 Church Street, 13th Floor, New York, NY 10007-2919
Tel: +1 212 417 4553 or +1 518 474 9866
Web site: www.hivguidelines.org
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 44
   
  
     
 
   
 
  
 
 
  
  
  
 
 
 
 
 
 
  
 
 
 
  
 
 
  
 
 
    
 
   
   
  
 
  
 
 
   
  
 
  
 
 
  
Tool 4.7
Title Harm Reduction Developments: Countries with Injection-Driven HIVEpidemics
Author /
Institution Open Society Institute, 2008
Description
This report provides key developments in HIV prevention, policy, and 
treatment for IDUs in developing and transitional countries with injection-
driven epidemics, and includes overviews on such issues as community
mobilization, methadone, and buprenorphine treatment availability, harm
reduction in prisons, and HIV treatment for IDUs.
Link to Tool http://www.soros.org/initiatives/health/focus/ihrd/articles_publications
/publications/developments_20080304
Source /
Contact
Open Society Institute
400 West 59th Street, New York, New York 10019 USA
Tel: +1 212 548 0111; Fax: +1 212 548 4617
Email: IHRD@sorosny.org
Web site: www.soros.org
Tool 4.8
Title
Best practice in HIV/AIDS prevention and care for injecting drug 
abusers: The Triangular Clinic in Kermanshah, Islamic Republic of
Iran
Author /
Institution Regional Office for the Eastern Mediterranean/WHO, 2004
Description
This document provides a case study of the Triangular Clinic in Iran which 
provides a comprehensive HIV prevention and care program for IDUs
focusing on the development and implementation of the Triangular Clinic
program.
Link to Tool www.emro.who.int/asd/PDF/STD-052.pdf
Source /
Contact
World Health Organization, Regional Office for the Eastern Mediterranean
P.O. Box 7608, Nasr City, Cairo 11371, Egypt
Tel: +202 670 2535; Fax: +202 670 2492
Email: DSA@emro.who.int
Web site: http://www.who.int/en/
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Tool 4.9
Title High Coverage Sites: HIV Prevention among Injecting Drug Users inTransitional and Developing Countries
Author /
Institution United Nations Joint Programme on HIV/AIDS, 2006
Description
This document discusses four case studies of high coverage countries in 
which over 50% of IDUS were reached by HIV prevention interventions and
describes the program and lessons learned.
Link to Tool http://data.unaids.org/Publications/IRC-pub07/JC1254-highCoverageIDU_en.pdf
Source /
Contact
UNAIDS Information Centre
20 avenue Appia, 1211 Geneva 27, Switzerland
Tel: +41 22 791 36 66; Fax: +41 22 791 41 87
E-mail: distribution@unaids.org
Web site: http://www.unaids.org
Tool 4.10
Title Prevention of transmission of HIV among Drug Users in the South Asian Association for Regional Co-operation (SAARC) Countries
Author /
Institution United Nations Office on Drugs and Crime: South Asia
Description
This document is a series of six modules, which together form an 
“Intervention Tool-kit” that will help in capacity building for field-level 
intervention teams to prevent HIV among drug users. The modules are: (1)
Introduction to Intervention Toolkit and basics of conducting rapid situation 
and response assessment; (2) Peer-led community outreach intervention 
for drug users; (3) Safer practices; (4) Buprenorphine substitution; (5)
Methadone substitution (Methadone Maintenance; and (6) Low-cost,
community-based care for drug users
Link to Tool http://www.unodc.org/india/en/prev_h13_modules.html
Source /
Contact
UNODC Regional Office for South Asia
(Responsible for India, Bangladesh, Bhutan, Maldives, Nepal, and Sri
Lanka)
Mr. Gary Lewis, Representative
P.O. Box 3059, New Delhi, India, 110 003 
Tel: +91 11 4222 5000 or 2410 4970/71/72/73
Fax: +91 11 2410 4962
Web site: http://www.unodc.org/southasia/
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CHAPTER 5: IMPLEMENTING HIV INTERVENTIONS AMONG PEOPLE WHO USE DRUGS
5.1: Implementing Interventions: Community Outreach 
Tool 5.1.1
Title The NIDA Community-Based Outreach Model: A Manual to Reduce the Risk of HIV and Other Blood-Borne Infections in Drug Users
Author /
Institution National Institute on Drug Abuse, 2000
Description
This paper describes the evidence for the effectiveness of community-
based outreach intervention as a component of a comprehensive HIV
prevention among drug users.
Link to Tool http://archives.drugabuse.gov/PDF/CBOM/Manual.pdf
Source /
Contact
SAMHSA’s National Clearinghouse for Alcohol and Drug Information
P.O. Box 2345, Rockville, MD 20847-2345
Tel: + 1 800 729 6686; Fax: + 1 240 221 4282
Web site: http://ncadi.samhsa.gov/
Tool 5.1.2
Title Effectiveness of community-based outreach in preventing HIV/AIDSamong injecting drug users
Author /
Institution
Richard H. Needle, Dave Burrows, Samuel R. Friedman, Jimmy Dorabjee,
Graziele Touze, Larissa Badreva, Jean-Paul C., Grund, Munirathinam
Suresh Kumar, Luciano Nigro, Greg Manning, and Carl Latkin, 2005
Description
This paper describes the evidence for the effectiveness of community-
based outreach intervention as a component of a comprehensive HIV
prevention program for drug users.
Link to Tool http://www.cdc.gov/outreach/background/NeedleRevIDU_Effects05.pdf
Source /
Contact
Needle, R. H., Burrows, D., Friedman, S. R., Dorabjee, J., Touze, G.,
Badrieva, L.,…Latkin, C. (2005). Effectiveness of community-based 
outreach in preventing HIV/AIDS among injecting drug users. International
Journal of Drug Policy, 16S, S45–S57.
Tool 5.1.3
Title Defining the Components of Street Outreach for HIV Prevention: theContact and the Encounter
Author /
Institution Jo Valentine and Linda Wright-De Aguero, 1996
Description
This paper describes two types of interactions that occur during outreach, the 
contact, and the encounter and suggests techniques for enhancing the
encounter between outreach workers and clients using the conceptual
framework of the social work helping relationship.
Link to 
Tool
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1382046/pdf/pubhealthrep00044-
0071.pdf
Source /
Contact
Valentine, J., & Wright-DeAguero, L. (1996). Defining the components of
street outreach for HIV prevention: the contact and the encounter. Public
Health Reports, 111(Supplement 1), 69–74.
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Tool 5.1.4
Title Evidence for Action: Effectiveness of Community Based Outreach
Author /
Institution World Health Organization, 2004
Description
This document presents evidence for effectiveness of community-based
outreach as a strategy for reaching and reducing HIV risk behaviors among 
IDUs
Link to Tool www.who.int/hiv/pub/idu/idu/en/
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/en/
Tool 5.1.5
Title Policy Brief: Reduction of HIV Transmission through Outreach
Author /
Institution
World Health Organization, United Nations Joint Programme on HIV/AIDS,
and United Nations Office on Drugs and Crime 2004
Description This policy brief provides evidence regarding the need for a strong
outreach component to reduce HIV transmission among IDUs
Link to Tool http://www.wpro.who.int/sites/hsi/documents/policy_brief_04_02.htm
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia,1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/en/
Tool 5.1.6
Title Training Guide for HIV Prevention Outreach to Injecting Drug Users
Author /
Institution World Health Organization, 2004
Description Four module training package designed to organize workshops that orient
and train people working in outreach to IDUs
Link to Tool http://www.who.int/hiv/pub/idu/hivpubidu/en/index.html
Source /
Contact
World Health Organization
Department of HIV/AIDS
20, Avenue Appia, 1211 Geneva 27, Switzerland
Tel: +41 22 791 2476; Fax: +41 22 791 4857
E-mail: hiv-aids@who.int
Web site: http://www.who.int/hiv/en
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5.2: Implementing Interventions: Risk Reduction Counseling
Tool 5.2.1
Title Guidelines for Behavior Change Communication: Enhancing Contentfor Harm Reduction Service Provision
Author /
Institution
Habib Ahmed Afser, Shazia Mohamed, AAHUNG; National AIDS Control
Programme, Ministry of Health, Government of Pakistan; and Futures
Group, 2007
Description
This document provides a multi-level tool for promoting voluntary behavior
change with tailor-made messages and a supportive environment for
reducing harm among drug users.
Link to Tool http://www.ahrn.net/library_upload/uploadfile/file1737.pdf
Source /
Contact
Habib Ahmed Afser, Shazia Mohamed, AAHUNG
Town House No. G-28/29
Embassy Villa 10, Ch. Khaliq-u-Zaman Road, Block 8, Clifton, Karachi,
Pakistan
Phone: +92 21 587 0244 & +92 21 582 1654
Email: aahung@cyber.net.pk
Tool 5.2.2
Title HIV/AIDS and injecting drug use: Information, education and communication
Author /
Institution Peter Aggleton, Paul Jenkins, and Anne Malcolm, 2005
Description
This article distinguishes and assesses 6 types of individual level drug use
interventions in which IEC plays a role (mass reach interventions, outreach,
harm reduction, drug treatment, VCT, risk reduction counseling).
Link to Tool http://linkinghub.elsevier.com/retrieve/pii/S0955395905000800
Source /
Contact
Aggleton, P., Jenkins, P., & Malcolm, A (2005). HIV/AIDS and injecting
drug use: Information, education and communication. International Journal
of Drug Policy, 16S, S21–S30.
Tool 5.2.3
Title HIV Transmission Guidelines for Assessing Risk 
Author /
Institution Canadian AIDS Council, 2004
Description
This document offers a framework for assessing risk of transmission of HIV
and hepatitis C virus (HCV), summarizes the implications of the current
medical and scientific evidence on HIV and HCV transmission, and
discusses risk reduction strategies.
Link to Tool http://www.cdnaids.ca/hivtransmissionguidelinesforassessi
Source /
Contact
Canadian AIDS Society
190 O'Connor St, Suite 800, Ottawa, ON K2P 2R3
Tel: +1 877 999 7740
Email: aidssida@cpha.ca
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Tool 5.2.4
Title Guidelines for Behavior Change Interventions to Prevent HIV: Sharing Lessons from an Experience in Bangladesh
Author /
Institution CARE/United Nations Joint Programme for HIV/AIDS, 2003
Description This document shares best practices from a targeted intervention in 
Bangladesh.
Link to Tool http://www.who.int/hiv/topics/vct/sw_toolkit/guidelines_behavior_change_b 
angladesh.pdf
Source /
Contact
UNAIDS Information Centre
20 avenue Appia, 1211 Geneva 27, Switzerland
Tel: +41 22 791 36 66; Fax: +41 22 791 41 87
E-mail: distribution@unaids.org
Web site: http://www.unaids.org
Tool 5.2.5
Title Interventions to reduce the sexual risk behaviour of injecting drug users
Author /
Institution Don C. Des Jarlais and Salaam Semaan, 2005
Description
This article conducts a qualitative and meta-analysis regarding interventions
to reduce sexual risk behavior among IDUs and the implications for global
research efforts and public health practice.
Link to 
Tool
http://www.journals.elsevierhealth.com/periodicals/drupol/article/PIIS09553 
95905000794/abstract
Source /
Contact
Des Jarlais, D. C. & Semaan, S. (2005). Interventions to reduce the sexual
risk behaviour of injecting drug users. International Journal of Drug Policy,
16, 58–66
Tool 5.2.6
Title Spreading the Light of Science: Guidelines on Harm Reduction Related to Injection Drug Use 
Author /
Institution International Federation of Red Cross and Red Crescent Societies,  2003
Description
The purpose of this document is to outline the rationale for harm reduction 
programs that National Societies can adapt to the realities of their countries
in the development and implementation of harm reduction programs and in 
conducting advocacy for the acceptance of such programs.
Link to Tool http://www.ifrc.org
Source /
Contact
International Federation of Red Cross and Red Crescent Societies
P.O. Box 372, CH-1211 Geneva 19, Switzerland
Tel: +41 22 730 4222; Fax: +41 22 733 0395
E-mail: secretariat@ifrc.org
Web site: www.ifrc.org
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Tool 5.2.7
Title Behavior Change and Health-Related Interventions for HeterosexualRisk Reduction Among Drug Users
Author /
Institution Salaam Semaan, Don C. Des Jarlais, and Rob Mallow, 2006
Description This article discusses the need for, and components of, behavior change 
and risk reduction in reducing sexually related HIV risk among drug users.
Link to Tool http://www.ncbi.nlm.nih.gov/pubmed/17002987
Source /
Contact
Semaan, S., Des Jarlais, D. C., & Malow, R. (2006). Behavior Change and
Health-Related Interventions for Heterosexual Risk Reduction among Drug 
Users. Substance Abuse and Misuse, 41, 1349–1378.
Tool 5.2.8
Title Bi-regional Strategy for Harm Reduction 2005–2009: HIV and InjectingDrug Use
Author /
Institution
World Health Organization, Regional Office for South-East Asia, and 
Regional Office for the Western Pacific, 2005
Description
The report provides a bi-regional strategy for Southeast Asia and Western 
Pacific Regions for reducing harm amongst IDUs from contracting and 
transmitting HIV/AIDS.
Link to Tool www.wpro.who.int/publications/PUB_9290611952.htm
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/en/
Implementing Interventions: Behavioral Intervention
Tool 5.2.9
Title
Safety Counts Program Manual: A Cognitive-Behavioral Intervention
to Reduce HIV/Hepatitis Risks Among Drug Users Who Are Not in 
Drug Treatment
Author /
Institution
Academy for Educational Development/Centers for Disease Control and
Prevention, 2006
Description
This manual provides guidance on implementing the Safety Counts
program into four parts: Part I provides an overview of the intervention, Part
II assists program managers on implementation, Part III provides
instructions for conducting sessions, and Part IV provides evaluation 
techniques.
Link to Tool http://effectiveinterventions.org/en/Interventions/SafetyCounts.aspx
Source /
Contact
Academy for Educational Development
Center on AIDS & Community Health 
Tel: +1 800 462 9521 or +1 202 884 8712
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Tool 5.2.10
Title Provisional Procedural Guidance for Community-based Organizations 
Author /
Institution Centers for Disease Control and Prevention, 2006
Description
This guidance gives information to help CBOs come up with a plan for
designing prevention programs and recruitment strategies to promote
counseling and testing, health education and risk reduction, and other
prevention services; counseling, testing, and referral strategies; and 
interventions to help prevent the spread of HIV to meet the needs of
persons living with HIV, their partners, and other persons who are not HIV-
infected, but are at very high risk for HIV.
Link to Tool www.effectiveinterventions.org
Source /
Contact
Diffusion of Effective Behavioral Interventions
Tel: +1 800 462 9521 
Email: interventions@aed.org
Tool 5.2.11
Title Self Help in Eliminating Life-Threatening Diseases (SHIELD)
Author /
Institution John Hopkins University/National Institute on Drug Abuse, 1997
Description
This manual provides instruction on SHIELD, a small-group, interactive 
intervention that relies on peer networks to reduce drug and sex risk
behaviors that lead to HIV, by using multiple training and skill-building
sessions
Link to Tool http://www.jhsph.edu/ShipStudies/Past_Projects/shield.html
Source /
Contact
Lighthouse Studies @ Peer Point
2213 McElderry Street, Baltimore, MD 21205-2414
Tel: +1 800 967 5710
Tool 5.2.12
Title
Best Evidence Interventions: Findings from a Systematic Review of
HIV Behavioral Interventions for US populations at High Risk, 2000-
2004
Author /
Institution
Lyles CM, Kay LS, Crepaz N, Herbst JH, Passin WF, Kim AS, Rama SM, 
Thadiparthi S, DeLuca JB, Mullins MM; HIV/AIDS Prevention Research
Synthesis Team, 2007
Description
This article provides a systematic review of US-based HIV behavioral
intervention research literature from 2000-2004 to identify interventions
demonstrating best evidence of efficacy for reducing HIV risk.
Link to Tool http://www.ajph.org/cgi/content/abstract/AJPH.2005.076182v1
Source /
Contact
Lyles, C. M., Kay, L. S., Crepaz, N., Herbst, J. H., Passin, W. F., Kim, A. 
S.,…Mullins, M. M. (2007). Best Evidence Interventions: Findings from a 
Systematic Review of HIV Behavioral Interventions for US populations at
High Risk, 2000–2004. American Journal of Public Health, 97 (1), 133–143.
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Tool 5.2.13
Title Choosing Life: Empowerment, Action, Results (CLEAR)
Author /
Institution
National Institute on Drug Abuse/University of California: Los Angeles,
2000
Description
CLEAR is a three-module intervention that is delivered in one-on-one
sessions to young people living with HIV to reduce high-risk behaviors,
especially substance abuse.
Link to Tool http://chipts.ucla.edu/interventions/manuals/intervclear.html
Source /
Contact
Center for HIV Identification, Prevention, and Treatment Services
(CHIPTS)
10920 Wilshire Blvd, Suite# 350, Los Angeles, CA 90024
Tel: +1 310 794 8278; Fax: + 1 310 794 8297
Web site: http://chipts.ucla.edu/about/index.asp
Tool 5.2.14
Title Female and Culturally Specific Negotiation Intervention TrainingManual
Author /
Institution Claire Sterk and Centers for Disease Control and Prevention, 1998
Description
In four individual sessions, the intervention explores the meaning of
gender-specific behaviors and social interactions, norms and values, and
power and control to reduce HIV risk behaviors among African-American
women who use crack or inject drugs.
Link to Tool http://www.cdc.gov/hiv/topics/research/prs/resources/factsheets/female.htm
Source /
Contact
Dr. Claire Sterk, Emory University, Rollins School of Public Health
Department of Behavior Sciences and Health Education
1518 Clifton Road N.E., Atlanta, GA 30322
Email: csterk@sph.emory.edu
Tool 5.2.15
Title Holistic Health Recovery Program Manual
Author /
Institution Yale/Centers for Disease Control and Prevention, 2005
Description
This manual provides guidance on a 12-session, group-level program
promoting abstinence from illicit drug use or from sexual risk behaviors,
reduced drug use, reduced risk for HIV transmission, and improved 
medical, psychological, and social functioning.
Link to Tool http://effectiveinterventions.org/en/Interventions/HolisticHealth.aspx
Source /
Contact
Diffusion of Effective Behavioral Interventions
Tel: +1 800 462 9521 
Email: interventions@aed.org
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5.3: Implementing Interventions: HIV Counseling and Testing
Tool 5.3.1
Title
Guidance on Testing and Counseling for HIV in Settings Attended by
People who Inject Drugs: Improving Access to Treatment, Care and
Prevention
Author /
Institution
World Health Organization South-East Asia Region and Western Pacific
Region/ United Nations Office on Drugs and Crimes Regional Centre for
East Asia and the Pacific, 2009
Description
This document offers basic operational guidance on HIV testing and
counseling in settings attended by people who inject drugs (PWID). It is
intended for a wide audience, including policy-makers, HIV/AIDS service
providers, and non-governmental organizations (NGOs) providing services
for HIV-related conditions and civil society groups providing services to 
PWID.
Link to Tool http://www.wpro.who.int/NR/rdonlyres/D243AA59-5C7A-4C0D-AF55-
4276E8DB62C7/0/GuidanceonTCinIDUsettings.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: premissions@who.int
Tool 5.3.2
Title Guidance on Provider-Initiated HIV Testing and Counseling in Health Facilities 
Author /
Institution
World Health Organization, The United Nations Joint Programme on
HIV/AIDS, 2007
Description This document provides basic operational guidance on provider-initiated 
HIV testing and counseling in health facilities.
Link to Tool http://whqlibdoc.who.int/publications/2007/9789241595568_eng.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: premissions@who.int
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Tool 5.3.3
Title Rapid HIV Tests: Guidelines for Use in HIV Testing and CounselingServices in Resource Constrained Settings
Author /
Institution World Health Organization, 2004
Description
This document reviews characteristics of rapid HIV tests for HIV testing 
and counseling and discusses practical issues and presents algorithm and
recommendations for their use.
Link to Tool http://www.aegis.com/files/who/rapidhivtestsen%5B1%5D.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: premissions@who.int
5.4 Implementing Interventions: Condom Promotion and Distribution 
Tool 5.4.1
Title Condoms and HIV Prevention: Position Paper
Author /
Institution
United Nations Population Fund, World Health Organization and United
Nations Joint Programme on HIV/AIDS, 2009
Description This document outlines the principles in condom programming, including 
promotion and distribution of condoms among high-risk populations
Link to Tool http://www.unfpa.org/hiv/docs/statement_condoms_HIV.pdf
Source /
Contact
UNFPA
220 East 42nd Street
New York, NY 10017 USA
Fax: +1.212.297-4915
Email: hiv@unfpa.org 
Web site: http://www.unfpa.org/
Tool 5.4.2
Title Condom effectiveness in reducing heterosexual HIV transmission.
Author /
Institution S. Weller and K. Davis, 2002
Description This article provides a comprehensive review of the existing evidence for
condom use for HIV prevention.
Link to 
Tool
http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD003255/pdf_fs. 
html
Source /
Contact
Weller, S. & Davis, K. (2002). Condom effectiveness in reducing 
heterosexual HIV transmission. Cochrane Database of Systematic
Reviews: CD003255
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5.5: Implementing Interventions: Access to and Safe Disposal of Injection Equipment
Tool 5.5.1
Title
Starting and Managing Needle and Syringe Exchange Programs: A
guide for Central and Eastern Europe and the newly independent
states of the former Soviet Union
Author /
Institution Burrows D., 2000 
Description
This document provides a comprehensive guide for setting up needle 
syringe programs in Central and Eastern Europe, and newly independent
ex-Soviet Union states.
Link to 
Tool http://www.soros.org/
Source /
Contact
Open Society Institute
International Harm Reduction Development
400 West 59th Street
New York, NY 10019 
Tel: +1 212-548-0677; Fax: +1 212-548-4617
Email: ihrd@sorosny.org
Web site: http://www.soros.org/
Tool 5.5.2
Title Syringe disinfection for IDUs
Author /
Institution
Centers for Disease Control and Prevention and Academy for Educational
Development, 2004
Description
This document provides basic information on syringe disinfection— 
specifically bleach disinfection—and lists the advantages and
disadvantages of various methods of syringe disinfection.
Link to Tool www.cdc.gov/idu/facts/disinfection.pdf
Source /
Contact
Centers for Disease Control and Prevention
1600 Clifton Road, MS – E-04, Atlanta, GA 30333
CDC Tel: +1 404 639 5230; AED Tel: +1 202 884 8952.
Web site: http://www.cdc.gov/idu
Tool 5.5.3
Title Guide to Starting and Managing Needle and Syringe Programmes
Author /
Institution World Health Organization, 2007
Description
This guide is designed to assist in expanding the response to HIV among 
injection drug users by offering guidance on developing a NSP, scaling up 
of programs, and establishing NSP in prison and other closed settings.
Link to Tool www.who.int/hiv/idu/OMSEA_NSP_Guide_100807.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: bookorders@who.int
Web site: http://www.who.int/en/
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Tool 5.5.4
Title Effectiveness of Sterile Needle and Syringe Programming in reducingHIV/AIDS among Injecting Drug Users
Author /
Institution World Health Organization, 2004
Description
This document evaluates evidence on the effectiveness of sterile needle 
and syringe programming for HIV prevention among IDUs and
recommends how this evidence can guide policy makers in programming 
for HIV prevention among IDUs
Link to Tool www.who.int/hiv/pub/prev_care/effectivenesssterileneedle.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: bookorders@who.int
Web site: http://www.who.int/en/
Tool 5.5.5
Title Policy Brief: Provision of Sterile Injecting Equipment to Reduce HIVTransmission
Author /
Institution World Health Organization, 2004
Description
This policy brief reviews current evidence regarding the benefit of including 
access to sterile injection equipment for IDUs as an essential component of
HIV/AIDS prevention programmes.
Link to Tool www.emro.who.int/aiecf/web32.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/en/
Tool 5.5.6
Title Effectiveness of sterile needle and syringe programmes
Author /
Institution Alex Wodak and Annie Cooney, 2005
Description This article provides a comprehensive overview of evidence for needle 
syringe programmes.
Link to Tool http://linkinghub.elsevier.com/retrieve/pii/S0955395905000782
Source /
Contact
Wodak, A., & Cooney, A. (2005). Effectiveness of sterile needle and
syringe programmes. International Journal of Drug Policy, 16S, S31–S44.
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5.6 Implementing Interventions: STI Screening and Treatment
Tool 5.6.1
Title Clinic Operational Guidelines & Standards: Comprehensive STIservices for Sex Workers in Avahan-Supported Clinics in India
Author /
Institution AVAHAN India AIDS Initiative & Family Health International, 2007
Description
This document, Clinic Operational Guidelines and Standards (COGS)
defines the minimum standards for STI services for Avahan-supported 
clinics and related community outreach. COGS were developed based on
an initial participatory assessment, Avahan-wide field experiences, existing 
Indian national guidelines, and inputs from technical experts.
Link to Tool http://www.fhi.org/NR/rdonlyres/ecpa2yfjgb56lm4fj3q52opc2fv5ioww32li762 
zibb22cosyxtejpqt6c6xrurktkaxw3mphkeacf/COGsHVenhv.pdf
Source /
Contact
Family Health International, FHI AIDS Institute
2101 Wilson Boulevard, Arlington, VA 22201
Tel: +1 703 516 9779; Fax: +1 703 516 9781
Web site: http://www.fhi.org 
Tool 5.6.2
Title Sexually transmitted and other reproductive tract infections: A guide to essential practice
Author /
Institution
World Health Organization, Family Health International, and The 
Population Council, 2005
Description This guide serves as a reference manual to screen and treat individuals for
STIs and RTIs in resource-constrained settings.
Link to Tool www.emro.who.int/aiecf/web79.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/en/
Tool 5.6.3
Title Guidelines for the management of sexually transmitted infections
Author /
Institution World Health Organization, 2003
Description
This guide provides recommendations for the comprehensive management
of patients with STIs within the broader context of control, prevention, and 
care programs for STI and HIV infection in resource-constrained settings.
Link to Tool www.emro.who.int/aiecf/web79.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/en/
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Tool 5.6.4
Title Management of common health problems of drug users
Author /
Institution World Health Organization, Regional Office for South-East Asia, 2007 
Description
These clinical guidelines are intended for use by doctors, nurses, and other
health care workers who work in community outreach, drop-in centers,
community clinics, drug treatment centers, prison clinics, and primary- and
secondary-level hospitals. It offers guidance on the provision of primary
health care to drug users and focuses on the clinical management of
common medical problems associated with drug use, in particular, injecting 
drug use in the presence or absence of HIV infection.
Link to Tool www.searo.who.int/hiv-aids publications.
Source /
Contact
HIV Unit, Department of Communicable Diseases
World Health Organization, Regional Office for South-East Asia,
Indraprastha Estate, Mahatma Gandhi Marg,
New Delhi 110 002, India,
E-mail: hiv@searo.who.int.
Tool 5.6.5
Title STDs among illicit drug users in the United States: The need forinterventions
Author /
Institution S. Semaan, D.C. Des Jarlais, R.M. Malow, 2007
Description
This chapter aims to review and summarize the literature on STDs
(excluding HIV) in drug users who engage in heterosexual behaviors and to 
describe the existing profile of STD-related prevention and control activities
specific to drug users.
Link to Tool http://www.springerlink.com/content/k160p01r2m2731q6/
Source /
Contact
Semaan, S., Des Jarlais, D. C., & Malow, R. M. (2007). STD among illicit
drug users in the United States: The need for interventions. In S. O. Aral &
J. M. Douglas (Eds.), Behavioral interventions for prevention and control of
sexually transmitted diseases (397-430). New York, NY: Springer Science 
+ Business Media.
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5.7: Implementing Interventions: HIV Care and Treatment among Drug Users
Tool 5.7.1
Title
Antiretroviral treatment for injecting drug users in developing and
transitional countries 1 year before the end of the ‘Treating 3 million 
by 2005. Making it happen. The WHO strategy’ (‘3by5’)
Author /
Institution
Carmen Aceijas, Edna Oppenheimer, Gerry V. Stimson, Richard E.
Ashcroft, Srdan Matic, and Matthew Hickman, 2006
Description
The article aims to describe and estimate the availability of antiretroviral
treatment (ART) to injecting drug users (IDUs) in developing and 
transitional countries.
Link to Tool http://www.who.int/hiv/idu/AddictionAbstractSept06.pdf
Source /
Contact
Aceijas, C., Oppenheimer, E., Stimson, G. V., Ashcroft, R. E., Matic, S., &
Hickman, M. (2006). Antiretroviral treatment for injecting drug users in 
developing and transitional countries 1 year before the end of the ‘Treating 
3 million by 2005. Making it happen. The WHO strategy’ (‘3by5’). Addiction,
101 (9), 1246–53.
Tool 5.7.2
Title Treatment and care for HIV-positive Injecting Drug Users
Author /
Institution
Association of South East Asian Nations, United States Agency for International
Development, World Health Organization, and Family Health International, 2007
Description
This is a set of training modules (12 modules) for clinicians who provide 
treatment and care, including antiretroviral therapy, for HIV-positive IDUs.
The curriculum identifies critical skills that will be needed by health givers
and clinicians in ensuring that HIV-positive IDUs are provided with high-
quality treatment
Link to Tool http://www.searo.who.int/en/Section10/Section18/Section356_14247.htm
Source /
Contact
The Association of Southeast Asian Nations (ASEAN) 
70 A, Jalan Sisingamangaraja
Jakarta 12110, Indonesia
Tel: + 1 62 21 724 3372
E-mail: public@aseansec.org
Website: www.aseansec.org
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Tool 5.7.3
Title
Evidence for Action: A critical tool for guiding policies and 
programmes for HIV prevention, treatment and care among injecting
drug users
Author /
Institution Andrew Ball, Monica Beg, Andrew Doupe, and Gundo A. Weiler, 2005
Description
The editorial provides a review of evidence regarding HIV prevention,
treatment, and care among IDUs, discusses the available literature
regarding HIV and IDUs, and points out the varying approaches to working 
with HIV and IDUs
Link to Tool http://linkinghub.elsevier.com/retrieve/pii/S0955395905001234
Source /
Contact
Ball, A., Beg, M., Doupe, A., & Weiler, G. A. (2005). Evidence for Action: A
critical tool for guiding policies and programmes for HIV prevention,
treatment and care among injecting drug users. International Journal of
Drug Policy, 16S, S1–S6.
Tool 5.7.4
Title Antiretroviral HIV treatment and care for injecting drug users: An evidence-based overview
Author /
Institution France Lert and Michel D. Kazatchkine, 2007
Description
This commentary provides a description of the evidence base to promote 
the need for large-scale implementation of comprehensive treatment and 
care strategies for IDUs that include both treatment of drug dependence 
and HIV/AIDS
Link to Tool http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2020510
Source /
Contact
Lert, F., & Kazatchkine, M. D. (2007). Antiretroviral HIV treatment and care 
for injecting drug users: An evidence-based overview. International Journal
of Drug Policy, 18, 255–261.
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Tool 5.7.5
Title
HIV and Substance Use Clinical Guidelines: Adherence to
Antiretroviral Therapy among Substance Users; Care of the
Hospitalized HIV-infected Substance User; Drug - Drug Interactions 
between HAART Medications Used in Substance Abuse Treatment
and Recreational Drugs; Medical Care of HIV infected Substance-
abusing Women; Mental Health Disorders Among Substance-using 
HIV-infected Patients; Pain in the HIV-infected Substance User
Author /
Institution New York Department of Health AIDS Institute, 2009
Description These documents provide guidance on treating and caring for HIV infected substance users.
Link to Tool
http://www.hivguidelines.org/clinical-guidelines/hiv-and-substance-use/
http://www.hivguidelines.org/wp-content/uploads/2009/06/s-adher.pdf
http://www.hivguidelines.org/wp-content/uploads/2009/06/s-hosp.pdf
http://www.hivguidelines.org/wp-content/uploads/2009/06/s-ddi.pdf
http://www.hivguidelines.org/wp-content/uploads/2009/06/s-women.pdf
http://www.hivguidelines.org/wp-content/uploads/2009/06/s-mh.pdf
http://www.hivguidelines.org/wp-content/uploads/2009/06/s-pain.pdf
Source /
Contact
AIDS Institute Office of the Medical Director
90 Church Street, 13th Floor, New York, NY 10007-2919
Tel: +1 212 417 4553 or +1 518 474 9866
Web site: www.hivguidelines.org
Tool 5.7.6
Title Breaking Down Barriers: Lessons on Providing HIV Treatment toInjection Drug Users
Author /
Institution Open Society Institute/International Harm Reduction Development, 2004
Description This document provides case studies from around the world offer effective 
strategies for treating HIV-infected IDUs.
Link to Tool www.soros.org/initiatives/ihrd
Source /
Contact
International Harm Reduction Development Program, Open Society
Institute
400 West 59th Street, New York, New York 10019 USA
Tel: +1 212 548 0677; Fax: +1 212 428 4617
Email: IHRD@sorosny.org
Web site: www.soros.org
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Tool 5.7.7
Title HIV/AIDS Treatment and Care for IDUs: Clinical Protocol for WHO European Region
Author /
Institution World Health Organization, 2007
Description The document provides clinical guidance on treatment and care for HIV-positive
drug users for the WHO European Region.
Link to 
Tool http://www.euro.who.int/__data/assets/pdf_file/0009/78138/E90840_Chapter_5.pdf
Source /
Contact
Publications Office
WHO Regional Office for Europe
Scherfigsvej 8 DK-2100 Copenhagen Ø, Denmark
Web site: www.euro.who.int/
Tool 5.7.8
Title Basic Principles for Treatment and Psychosocial Support of Drug Dependent People Living with HIV/AIDS
Author /
Institution World Health Organization, 2006
Description
This document provides central principles for treatment and support of HIV-
positive IDUs as well as a tool to stimulate coordination and communication 
among health care providers in delivery systems.
Link to Tool www.who.int/entity/substance_abuse/publications/basic_principles_drug_hiv.pdf
Source /
Contact
Marketing and Dissemination 
World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: bookorders@who.int
Web site: http://www.who.int/en/
Tool 5.7.9
Title Treatment of injecting drug users with HIV/AIDS: promoting access and optimizing service delivery
Author /
Institution World Health Organization, 2006
Description
This document aims to describe approaches to enhancing the management of
HIV-positive IDUs and discuss issues regarding implementation of interventions to
this population.
Link to 
Tool www.who.int/entity/substance_abuse/publications/treatment_idus_hiv_aids.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/en/
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Tool 5.7.10
Title Policy Brief: Antiretroviral Therapy and Injecting Drug Users
Author /
Institution
World Health Organization, United Nations Joint Programme on HIV/AIDS
and United Nations Office on Drugs and Crime, 2005
Description The policy brief provides evidence on ARV therapy to HIV-positive IDUs
and successful programs for IDUs.
Link to Tool www.who.int/hiv/pub/prev_care/arvidu.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/en/
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5.8: Implementing Interventions: Treatment for Drug Use and Dependence
Tool 5.8.1
Title Combating the Twin Epidemics of HIV/AIDS and Drug Addiction
Author /
Institution
Center for Strategic and International Studies; David Fiellin, Traci C.
Green, and Robert Heimer, 2008
Description
This paper reviews the need for medication-assisted maintenance 
treatment as part of an essential HIV prevention intervention, details the 
medical nature of opioid addiction, assesses the availability of treatment in 
12 developing countries, and offers recommendations for integration of
drug treatment services and HIV prevention efforts.
Link to Tool http://csis.org/files/media/csis/pubs/080129_fiellincombatinghiv.pdf
Source /
Contact
Center for Strategic and International Studies
1800 K Street, NW, Washington DC, 20006
Tel: +1 202 887 0200; Fax:+1 202 775 3199
Web site: https://www.csis.org/
Tool 5.8.2
Title Behavioral Drug and Risk Counseling for Opioid DependentIndividuals
Author /
Institution
Marek C. Chawarski, Declan T. Barry, Mahmud Mazlan, and Richard S.
Schottenfeld, 2006
Description
This manual provides guidance for implementing behavioral drug and HIV
risk counseling (BDRC) for individualized treatment for participants who are 
diagnosed with opiate dependence and currently abusing illicit opiates.
Link to 
Tool
http://www.hptn.org/web%20documents/HPTN058/ImplementationMaterials/
BDRCManualForHPTN058RevisedMay2006.pdf
Source /
Contact
SAMHSA’s National Clearinghouse for Alcohol and Drug Information
P.O. Box 2345, Rockville, MD 20847-2345
Tel: + 1 800 729 6686; Fax: + 1 240 221 4282
Web site: http://ncadi.samhsa.gov/
Tool 5.8.3
Title About Methadone
Author /
Institution Drug Policy Alliance, 2003
Description
This document provides information regarding the use of Methadone to 
treat opiate addiction and is geared towards both those taking methadone
and those who may provide treatment.
Link to Tool http://www.drugpolicy.org/
Source /
Contact
Drug Policy Alliance
70 West 36th Street 16th Floor, New York, NY 10018
Tel: (212) 613-8020; Fax: (212) 613-8021
E-mail: membership@drugpolicy.org
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Tool 5.8.4
Title Effectiveness of drug dependence treatment in HIV prevention
Author /
Institution
Michael Farrell, Linda Gowing, John Marsden, Walter Ling, and Robert Ali,
2005
Description This document provides a review of the effectiveness of drug dependence
treatment in preventing HIV transmission among IDUs.
Link to Tool http://linkinghub.elsevier.com/retrieve/pii/S0955395905000848
Source /
Contact
Farell, M., Gowing, L., Marsden, J., Ling, W., & Ali, R. (2005). Effectiveness
of drug dependence treatment in HIV prevention. International Journal of
Drug Policy, 16S, S67–S75.
Tool 5.8.5
Title Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Author /
Institution R.P. Mattick, J. Kimber, C. Breen, and M. Davoli, 2003
Description
A chocrane review which evaluated the effects of buprenorphine 
maintenance against placebo and methadone maintenance in retaining 
patients in treatment and in suppressing illicit drug use.
Link to 
Tool http://www.cochrane.org/reviews/en/ab002207.html
Source /
Contact
Mattick, R. P., Kimber J., Breen C., & Davoli M. Buprenorphine 
maintenance versus placebo or methadone maintenance for opioid 
dependence. The Cochrane Database of Systematic Reviews 2003, Issue
2. pub2.
Tool 5.8.6
Title Principles of Drug Addiction Treatment: A Research-Based Guide
Author /
Institution National Institute on Drug Abuse, 2009
Description
This document is intended to address addiction to a wide variety of drugs,
including nicotine, alcohol, and illicit and prescription drugs. It is designed
to serve as a resource for health care providers, family members, and other
stakeholders trying to address the myriad of problems faced by patients in 
need of treatment for drug abuse or addiction.
Link to Tool http://www.drugabuse.gov/PDF/PODAT/PODAT.pdf
Source /
Contact
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard, Room 5213
Bethesda, MD 20892-9561
Tel: + 1 877 643 2644; Fax: + 1-240-645-0227
Email: drugpubs@nida.nih.gov
Web site: www.drugabuse.gov
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Tool 5.8.7
Title Treatment Approaches for Drug Addiction
Author /
Institution National Institute on Drug Abuse, 2009
Description This is a fact sheet covering research findings on effective treatment
approaches for drug abuse and addiction.
Link to Tool http://www.nida.nih.gov/PDF/InfoFacts/IF_Treatment_Approaches_2009_to 
_NIDA_92209.pdf
Source /
Contact
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard, Room 5213
Bethesda, MD 20892-9561
Tel: + 1 877 643 2644; Fax: + 1-240-645-0227
Email: drugpubs@nida.nih.gov
Web site: www.drugabuse.gov
Tool 5.8.8
Title Methadone Research Web Guide
Author /
Institution National Institute on Drug Abuse, 2006
Description
This guide provides an overview of research supporting methadone
maintenance as an option for opiod dependency treatment from the United
States, answers frequently asked questions, and includes best practices
and treatment protocols
Link to Tool http://international.drugabuse.gov/sites/default/files/pdf/methadoneresearch 
webguide.pdf
Source /
Contact
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard, Room 5213
Bethesda, MD 20892-9561
Tel: + 1 877 643 2644; Fax: + 1-240-645-0227
Email: drugpubs@nida.nih.gov
Web site: www.drugabuse.gov
Tool 5.8.9
Title HIV and Substance Use Clinical Guidelines: Substance Use TreatmentModalities for HIV-Infected Persons
Author /
Institution New York Department of Health AIDS Institute, 2009
Description This document provides information and recommendations regarding
various substance abuse treatment modalities for HIV-infected persons.
Link to Tool http://www.hivguidelines.org/wp-content/uploads/2009/05/s-treat.pdf
Source /
Contact
NYDOH AIDS Institute Office of the Medical Director
90 Church Street, 13th Floor, New York, NY 10007-2919
Tel: +1 212 417 4553 or +1 518 474 9866
Web site: www.hivguidelines.org
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Tool 5.8.10
Title HIV and Substance Use Clinical Guidelines: Screening and OngoingAssessment for Substance Use
Author /
Institution New York Department of Health AIDS Institute, 2007
Description This document provides guidance on screening HIV-positive individuals for
substance use, abuse and dependence.
Link to Tool http://www.hivguidelines.org/wp-content/uploads/2009/05/s-screening.pdf
Source /
Contact
NYDOH AIDS Institute Office of the Medical Director
90 Church Street, 13th Floor, New York, NY 10007-2919
Tel: +1 212 417 4553 or +1 518 474 9866
Web site: www.hivguidelines.org
Tool 5.8.11
Title
Treatment Improvement Protocols (TIPS): Substance Abuse: Clinical
Issues in Intensive Outpatient treatment; Medication-assisted
Treatment for Opioid addiction in opioid treatment programs;
Treatment for Stimulant Use Disorders; Substance Abuse Treatment
for Persons with HIV/AIDS; Substance Abuse Treatment and Family
Therapy; Clinical Guidelines for the Use of Buprenorphine in the
Treatment of Opioid Addiction; Detoxification and Substance Abuse 
Treatment; Brief Interventions and Brief Therapies for Substance 
Abuse
Author /
Institution Substance Abuse and Mental Health Services Administration, 2010
Description TIPs are best practice guidelines for the treatment of drug abuse and 
dependence.
Link to Tool http://tie.samhsa.gov/Externals/tips.html
Source /
Contact
SAMHSA’s National Clearinghouse for Alcohol and Drug Information
P.O. Box 2345, Rockville, MD 20847-2345
Tel: + 1 800 729 6686; Fax: + 1 240 221 4282
Web site: http://ncadi.samhsa.gov/
Tool 5.8.12
Title Buprenorphine: A Guide for Pharmacists
Author /
Institution Substance Abuse and Mental Health Services Administration, 2007
Description This guide provides pharmacists with an introduction to the clinical, legal,
and regulatory aspects of opioid addiction treatment with buprenorphine.
Link to Tool http://buprenorphine.samhsa.gov/SAMHSA_reports.html
Source /
Contact
SAMHSA’s National Clearinghouse for Alcohol and Drug Information
P.O. Box 2345, Rockville, MD 20847-2345
Tel: + 1 800 729 6686; Fax: + 1 240 221 4282
Web site: http://ncadi.samhsa.gov/
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Tool 5.8.13
Title Principles of Drug Dependence Treatment: Discussion Paper
Author /
Institution United Nations Office on Drugs and Crime, 2009
Description
This discussion paper aims to encourage governments and other partners
to take concerted action for the implementation of evidence-based drug 
dependence treatment services, which respond to the needs of their local,
drug-using populations.
Link to Tool http://www.unodc.org/documents/eastasiaandpacific//china/UNODC-WHO-
Principles-of-Drug-Dependence-Treatment.pdf
Source /
Contact
United Nations Publications, Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027
Web site: www.unodc.org
Tool 5.8.14
Title Substance Abuse Treatment and care for women: Case studies andlessons learned
Author /
Institution United Nations Office on Drugs and Crime, 2004
Description
This publication provides tools, suggestions, and practical examples for
overcoming access barriers, engaging women in substance abuse 
treatment, and providing treatment that is responsive to the specific needs
of women.
Link to 
Tool http://www.unodc.org/docs/treatment/Guide_E.pdf
Source /
Contact
United Nations Publications, Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027
Web site: www.unodc.org
Tool 5.8.15
Title Drug Abuse Treatment and Rehabilitation: a Practical Planning and Implementation Guide
Author /
Institution United Nations Office on Drugs and Crime, 2003
Description
This guide provides a framework to assist program planners and
implementers in developing or enhancing drug treatment and rehabilitation
services.
Link to Tool http://www.unodc.org/docs/treatment/Guide_E.pdf
Source /
Contact
United Nations Publications, Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027
Web site: www.unodc.org
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Tool 5.8.16
Title Guidelines for the psychosocially assisted pharmacological treatmentof opioid dependence 
Author /
Institution World Health Organization, 2009
Descriptio 
n
This document provides guidance on implementing psychosocially assisted
pharmacological treatment to reduce both illicit opioid use and harms related 
to opioid use and improve quality of life.
Link to 
Tool
http://www.who.int/substance_abuse/publications/opioid_dependence_guidel 
ines.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
Tool 5.8.17
Title Evidence for Action: Effectiveness of Drug Dependence Treatment inPreventing HIV among Injection Drug Users
Author /
Institution World Health Organization, 2005
Description This document reviews the effectiveness of drug dependence 
interventions.
Link to Tool www.emro.who.int/aiecf/web203.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
Tool 5.8.18
Title Policy Brief: Reduction of HIV Transmission through Drug-Dependence Treatment
Author /
Institution World Health Organization, 2004
Description This policy brief reviews the evidence regarding drug dependence
programs and their usefulness in reducing HIV transmission.
Link to Tool www.emro.who.int/aiecf/web33.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
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Tool 5.8.19
Title
The Practices and Context of Pharmacotherapy of Opiod Dependence 
in Central and Eastern Europe
Author /
Institution World Health Organization, 2004
Description
This document describes the current opiod situation in Central and Eastern 
Europe as well the role of pharmacotherapy for opiod dependence.
Link to Tool www.who.int/substance_abuse/publications/treatment/en/index.html
Source /
Contact
Marketing and Dissemination, World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
email: permissions@who.int
Web site: http://www.who.int/
Tool 5.8.20
Title
The Alcohol, Smoking and Substance Involvement Screening Test
(ASSIST): Guidelines for Use in Primary Care, Draft
Author /
Institution World Health Organization, 2003
Descriptio 
n
The purpose of this manual is to introduce the ASSIST and to describe how
to use it in primary health care settings to identify people with hazardous or
harmful drug use. The manual describes: reasons to ask about alcohol and
other drug use; the context of substance involvement screening; the 
development and validation of the ASSIST; how to use the ASSIST tool;
how to help patients who screen positive; and how to use the ASSIST in 
everyday practice.
Link to 
Tool
http://www.who.int/substance_abuse/activities/en/Draft_The_ASSIST_Guid 
elines.pdf
Source /
Contact
Marketing and Dissemination, World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
email: permissions@who.int
Web site: http://www.who.int/
Tool 5.8.21
Title Brief Intervention for Substance Use: A Manual for use in PrimaryCare, Draft
Author /
Institution World Health Organization, 2003
Description
The purpose of this manual is to explain the theoretical basis and evidence 
for brief intervention and to assist primary health care workers in
conducting a simple brief intervention for risky or harmful drug use.
Link to Tool http://www.adp.cahwnet.gov/SBI/pdfs/Brief_Intervention.pdf
Source /
Contact
Marketing and Dissemination, World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
email: permissions@who.int
Web site: http://www.who.int/
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Tool 5.8.22
Title Self-Help Strategies for Cutting Down or Stopping Substance Use: AGuide, Draft
Author /
Institution World Health Organization, 2003
Description
This document provides guidance to people who use drugs on decreasing 
drug use and living healthier lives.
Link to Tool http://www.who.int/substance_abuse/activities/en/Draft_Substance_ Use_Guide.pdf
Source /
Contact
Marketing and Dissemination, World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
email: permissions@who.int
Web site: http://www.who.int/
Tool 5.8.23
Title Substitution maintenance therapy in the management of opioddependence and HIV/AIDS prevention
Author /
Institution
World Health Organization, United Nations Office on Drugs and Crime, and 
United Nations Joint Programme on HIV/AIDS, 2004
Description
This document provides evidence and discussion regarding the
advantages of substitution therapy to assist opiod-addicted individuals, as
well as how this can serve to decrease HIV/AIDS transmission.
Link to Tool www.who.int/substance_abuse/publications/treatment/en/index.html
Source /
Contact
Marketing and Dissemination, World Health Organization 
20, Avenue Appia,1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
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5.9: Implementing Interventions: Prevention, Diagnosis and Treatment of Tuberculosis (TB)
Tool 5.9.1
Title Evidence for Action: Policy guidelines for collaborative TB and HIVservices for injecting and other drug users: an integrated approach
Author /
Institution World Health Organization, 2008
Description
The aim of these guidelines is to provide guidance to individuals working 
with drug users on developing a strategic approach to reducing morbidity
and mortality related to TB and HIV among at-risk drug users and their
communities.
Link to Tool http://whqlibdoc.who.int/publications/2008/9789241596930_eng.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 3264; Fax: +41 22 791 4857
Email: bookorders@who.int
Web site: http://www.who.int/
Tool 5.9.2
Title Policy Brief: Policy guidelines for collaborative TB and HIV servicesfor injecting and other drug users
Author /
Institution World Health Organization, 2008
Description
This policy brief summarizes the evidence and recommendations in the
Policy guidelines for collaborative TB and HIV services for injecting and 
other drug users, which were developed by WHO, in collaboration with 
UNODC and UNAIDS, and in consultation with a group of technical
experts.
Link to Tool http://whqlibdoc.who.int/publications/2008/9789241596947_eng.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 3264; Fax: +41 22 791 4857
Email: bookorders@who.int
Web site: http://www.who.int/
Tool 5.9.3
Title TB/HIV: A clinical manual
Author /
Institution World Health Organization, 2004
Description
This manual provides guidance to clinicians about caring for patients
(including PWID) with TB/HIV.
Link to Tool http://whqlibdoc.who.int/publications/2004/9241546344.pdf
Source /
Contact
Marketing and Dissemination, World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
email: bookorders@who.int
Web site: http://www.who.int/
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5.10: Implementing Interventions: Vaccination, Diagnosis and Treatment of Viral Hepatitis
Tool 5.10.1
Title Viral Hepatitis and Injection Drug Users
Author /
Institution
Centers for Disease Control and Prevention and Academy for Educational
Development, 2002
Description This fact sheet provides key information on viral hepatitis among people
who inject drugs.
Link to Tool http://www.cdc.gov/idu/hepatitis/viral_hep_drug_use.pdf
Source /
Contact
Global AIDS Program, NCHHSTP
Centers for Disease Control and Prevention
1600 Clifton Road, MS E-30, Atlanta, GA 30333
Web site: http://www.cdc.gov/idu
Tool 5.10.2
Title Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C
Author /
Institution Institute of Medicine, 2010
Description
This document reviews current prevention and control activities and 
identifies future priorities for research, policy, and action to reduce new
HBV and HCV infections and the morbidity and mortality related to chronic
viral hepatitis.
Link to Tool http://www.nap.edu/catalog/12793.html
Source /
Contact
National Academies Press
500 Fifth Street, N.W., Lockbox 285
Washington, DC 20055;
Tel: (800) 624-6242 or (202) 334-3313
Email: bookorders@who.int
Web site: www.nap.edu
Tool 5.10.3
Title HIV and Substance Use Clinical Guidelines: Aspects of Primary Carefor the HIV-Infected Substance User
Author /
Institution New York Department of Health AIDS Institute, 2009
Description Provides guidance on providing primary care to HIV-positive substance users, including viral hepatitis.
Link to Tool http://www.hivguidelines.org/clinical-guidelines/hiv-and-substance-use/aspects-of-primary-care-for-the-hiv-infected-substance-user/
Source /
Contact
NYDOH AIDS Institute Office of the Medical Director
90 Church Street, 13th Floor, New York, NY 10007-2919
Tel: +1 212 417 4553 or +1 518 474 9866
Web site: www.hivguidelines.org
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 74
   
  
    
 
   
 
     
  
 
  
  
 
  
 
 
  
  
 
  
  
 
Tool 5.10.4
Title Management of common health problems of drug users
Author / 
Institution World Health Organization, Regional Office for South-East Asia, 2009
Description
These clinical guidelines are intended for use by doctors, nurses, and other
health care workers who work in community outreach, drop-in centers,
community clinics, drug treatment centers, prison clinics, and hospitals.
They offer guidance on the provision of primary health care to drug users
and focus on the clinical management of common medical problems
associated with drug use in the presence or absence of HIV infection.
Link to Tool http://www.searo.who.int/LinkFiles/HIV-AIDS_Primary_care_guidelines.pdf
Source /
Contact
HIV Unit, Department of Communicable Diseases
World Health Organization, Regional Office for South-East Asia
Indraprastha Estate, Mahatma Gandhi Marg
New Delhi 110 002, India 
E-mail: hiv@searo.who.int.
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CHAPTER 6: IMPLEMENTING HIV INTERVENTIONS AMONG INCARCERATED PEOPLE 
WHO USE DRUGS
Tool 6.1
Title Prison Needle Exchange: Lessons from a Comprehensive Review ofInternational Evidence and Experience
Author /
Institution Canadian HIV/AIDS Legal Network, 2006
Description
This report provides a comprehensive review of the evidence for prison
needle exchange programs. The goal of this report is to encourage prison 
systems with HIV and HCV epidemics driven by injection drug use to 
implement needle exchange programs.
Link to Tool http://www.aidslaw.ca/publications/interfaces/downloadFile.php?ref=1173
Source /
Contact
Canadian HIV/AIDS Legal Network
Tel: +1 416 595-1666; Fax: +1 416 595-0094
Email: info@aidslaw.ca
Web site: www.aidslaw.ca
Tool 6.2
Title Treatment Improvement Protocol (TIP) 44: Substance Abuse Treatment for Adults in the Criminal Justice System
Author /
Institution Substance Abuse and Mental Health Services Administration, 2005
Description This document provides best practices for substance abuse treatment in 
the criminal justice system.
Link to Tool http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=hssamhsatip&part
=A80017
Source /
Contact
SAMHSA’s National Clearinghouse for Alcohol and Drug Information
P.O. Box 2345, Rockville, MD 20847-2345
Tel: + 1 800 729 6686; Fax: + 1 240 221 4282
Web site: http://ncadi.samhsa.gov/
Tool 6.3
Title Substance Abuse Treatment for Women Offenders: Guide to Promising Practices
Author /
Institution Substance Abuse and Mental Health Services Administration, 2002
Description This document offers helpful guidelines and ideas for designing promising
programs to help addicted women in the criminal justice system.
Link to 
Tool http://kap.samhsa.gov/products/manuals/taps/23.htm
Source /
Contact
SAMHSA’s National Clearinghouse for Alcohol and Drug Information
P.O. Box 2345, Rockville, MD 20847-2345
Tel: + 1 800 729 6686; Fax: + 1 240 221 4282
Web site: http://ncadi.samhsa.gov/
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Tool 6.4
Title HIV/AIDS in places of detention: A toolkit for policy makers,managers, and staff
Author /
Institution United Nations Office on Drugs and Crime, 2007
Description
This toolkit is designed to assist countries in their efforts to mount an
effective national response to HIV/AIDS in prisons and to improve and, if
necessary, reform their prison systems.
Link to Tool www.unodc.org/unodc/en/hiv-aids/publications.html
Source /
Contact
United Nations Publications, Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027
Web site: www.unodc.org
Tool 6.5
Title Preventing Drug Use and HIV among Incarcerated Substance Users:Module for Prison Intervention
Author /
Institution United Nations Office on Drugs and Crime, 2007
Description
The objective of this curriculum is to sensitize the prison community to 
drugs and HIV issues and to create an enabling environment for
advocating a comprehensive package of services for prevention of HIV.
Link to Tool www.unodc.org/pdf/india/publications/Prison_module.pdf
Source /
Contact
United Nations Publications, Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027
Web site: www.unodc.org
Tool 6.6
Title HIV/AIDS Prevention, Care, Treatment, and Support in Prison Settings
Author /
Institution United Nations Office on Drugs and Crime, 2006
Description This document provides a framework for developing an evidence-based 
national response to HIV/AIDS in prisons.
Link to Tool www.unodc.org/pdf/HIV-AIDS_prisons_July06.pdf
Source /
Contact
United Nations Publications, Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027
Web site: www.unodc.org
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Tool 6.7
Title Women and HIV in Prison Settings
Author /
Institution
United Nations Office on Drugs and Crime and United Nations Programme 
on HIV/AIDS, 2008
Description This document provides an overview of HIV risk among women in closed settings.
Link to Tool http://www.unodc.org/documents/hiv-
aids/Women%20and%20HIV%20in%20prison%20settings.pdf
Source /
Contact
United Nations Publications, Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027
Web site: www.unodc.org
Tool 6.8
Title HIV and Prisons in sub-Saharan Africa: Opportunities for Action
Author /
Institution
United Nations Office on Drugs and Crime, United Nations Programme on 
HIV/AIDS, and The World Bank, 2007
Description
This document presents a summary of existing information on HIV among
prison communities in sub-Saharan Africa, identifies gaps in information,
and proposes a framework for action.
Link to Tool www.unodc.org/unodc/en/frontpage/hiv-and-prisons-in-sub-saharan-
africa.html
Source /
Contact
United Nations Publications, Sales Office and Bookshop
CH-1211, Geneva 10, Switzerland 
Tel: 41 (22) 917-2614; Fax: 41 (22) 917-0027
Web site: www.unodc.org
Tool 6.9
Title Effectiveness of interventions to address HIV in prisons
Author /
Institution World Health Organization, 2007
Description This document provides evidence and best practices for HIV prevention,
care, and treatment in prisons.
Link to Tool http://www.who.int/hiv/idu/
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
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Tool 6.10
Title Interventions to address HIV in Prisons: Drug Dependence Treatment
Author /
Institution World Health Organization, 2007
Description This document reviews and assesses the evidence for drug dependence
treatment in prison settings.
Link to Tool http://www.who.int/hiv/idu/
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
Tool 6.11
Title Interventions to Address HIV in Prisons: HIV Care, Treatment, andSupport
Author /
Institution World Health Organization, 2007
Description This document reviews and assesses the evidence for HIV care, treatment,
and support programs in prison settings.
Link to Tool http://www.who.int/hiv/idu/
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
Tool 6.12
Title Interventions to Address HIV in Prisons: Needle and Syringe Exchange Programmes and Decontamination Strategies
Author /
Institution World Health Organization, 2007
Description This document reviews and assesses the evidence for needle and syringe
exchange programs in prisons.
Link to Tool http://www.who.int/hiv/idu/
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
Toolkit for Implementing Programs for People Who Use Drugs (PWUD) 79
   
   
     
 
  
   
 
  
 
 
 
   
    
  
 
 
 
   
  
 
  
    
   
  
 
 
 
  
    
  
 
 
 
  
  
 
   
 
 
  
 
 
 
  
    
  
 
 
  
Tool 6.13
Title Interventions to Address HIV in Prisons: Prevention of SexualTransmission
Author /
Institution World Health Organization, 2007
Description This document reviews and assesses the evidence for prevention of sexual
transmission among prison populations.
Link to Tool http://www.who.int/hiv/idu/
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
Tool 6.14
Title Inside Out: HIV Harm Reduction Education for Closed Settings
Author /
Institution World Health Organization, 2007
Description Training manual that provides instruction on preventing the spread of HIV
for staff and residents in drug treatment and rehabilitation centers.
Link to Tool http://www.wpro.who.int/publications/PUB_978+92+9061+221+6.htm
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
Tool 6.15
Title Policy Brief: Reduction of HIV Transmission in Prisons
Author /
Institution World Health Organization, 2004
Description This document summarizes the evidence for HIV prevention programs in 
prisons.
Link to Tool http://www.who.int/hiv/pub/idu/idupolicybriefs/en/index.html
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: permissions@who.int
Web site: http://www.who.int/
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Tool 6.16
Title Looking Inside and Affecting the Outside: Corrections-Based Interventions for STD Prevention
Author /
Institution Samantha Williams and Richard Kahn, 2007
Description This article describes the current literature and interventions targeted
towards correction-based populations and STD prevention.
Link to Tool http://www.springerlink.com/content/w4348p2641860337/
Source /
Contact
Behavioral Interventions for STDs: Theoretical Models and Intervention 
Methods. In J. M. Douglas (Ed.) & J. A. Lipshutz (Assoc Ed.), Behavioral
Interventions for Prevention and Control of Sexually Transmitted Diseases
(pp. 374–396).
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CHAPTER 7: MEASURING PROGRESS AND EVALUATING HIV INTERVENTIONS AMONG 
DRUG-USING POPULATIONS
Tool 7.1 
Title Monitoring & Evaluation Capacity Building for ProgramImprovement Field Guide
Author /
Institution Centers for Disease Control and Prevention, 2004
Description
This field guide provides guidance on building the capacity of HIV/AIDS-
related programs and initiatives with the aim to improve programs and 
measure the success and impact of projects and countrywide programs.
The guide also addresses ways in which monitoring and evaluation data
may be used to inform and improve programs implemented in
partnership.
Link to Tool N/A
Source /
Contact
Global AIDS Program, NCHHSTP
Centers for Disease Control and Prevention
1600 Clifton Road, MS E-30, Atlanta, GA 30333
E-mail: drugg@cdc.gov
Web site: www.cdc.gov
Tool 7.2
Title A Framework for Monitoring and Evaluating HIV PreventionProgrammes for Most-At-Risk Populations
Author /
Institution United Nations Joint Programme on HIV/AIDS, 2007
Description
This document provides an overview of M&E methods and approaches
for most-at- risk populations. It also covers the use of strategic
information for program planning, monitoring, and evaluation.
Link to Tool http://data.unaids.org/pub/Manual/2008/jc1519_framework_for_me_en.p 
df
Source /
Contact
UNAIDS Information Centre 
20 Avenue Appia, 1211 Geneva 27 Switzerland 
Tel: +41 22 791 36 66; Fax: +41 22 791 48 35
E-mail: distribution@unaids.org
Web site: www.unaids.org
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Tool 7.3
Title Guidelines for Effective Use of Data from Surveillance Systems
Author /
Institution
World Health Organization and United Nations Joint Programme on
HIV/AIDS, 2004
Description This document provides guidance on effectively using surveillance data 
for program planning, monitoring, evaluation, and advocacy.
Link to Tool http://www.who.int/hiv/strategic/surveillance/en/useofdata.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: bookorders@who.int
Web site: http://www.who.int/
Tool 7.4
Title
Technical Guide for Countries to set Targets for Universal Access 
to HIV Prevention, Treatment, and Care for Injecting Drug Users
(IDUs)
Author /
Institution
World Health Organization, United Nations Office on Drugs and Crime,
and United Nations Joint Programme on HIV/AIDS, 2009
Description
This document provides technical guidance to countries on setting
ambitious, but achievable, national targets for scaling-up towards
Universal Access to HIV/AIDS prevention, treatment, and care for
Injecting Drug Users (IDUs).
Link to Tool
http://www.unodc.org/documents/hiv-
aids/WHO%20UNODC%20UNAIDS%20%20IDU%20Universal%20Acce 
ss%20Target%20Setting%20Guide%20-%20FINAL%20-
%20Feb%2009.pdf
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 791 4857
Email: bookorders@who.int
Web site: http://www.who.int/
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CHAPTER 8: HIV PREVENTION AMONG DRUG USING POPULATIONS ADVOCACY AND 
POLICY
Tool 8.1
Title International Guidelines on HIV/AIDS and Human Rights
Author /
Institution United Nations Joint Programme on HIV/AIDS, 2006
Description This document provides current guidelines on HIV and human rights.
Link to Tool http://www1.umn.edu/humanrts/instree/t4igha.html
Source /
Contact
UNAIDS Information Centre
20 avenue Appia, 1211 Geneva 27, Switzerland
Tel: +41 22 791 36 66; Fax: +41 22 791 41 87
E-mail: distribution@unaids.org
Web site: http://www.unaids.org
Tool 8.2
Title Policy and Programming Guide for HIV/AIDS Prevention and Care among Drug Users
Author /
Institution World Health Organization, 2004
Description
This guide distills principles from policies and programs that have 
worked and provides an overview of how to develop a comprehensive 
and effective response to HIV among drug users and provides a list of
characteristics of effective programs. The guide is designed to be
used with RAR guides, advocacy, and other guides.
Link to Tool http://www.who.int/hiv/pub/advocacy/idu/en/
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia, 1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 731 4857
Email: bookorders@who.int
Web site: http://www.who.int/
Tool 8.3 
Title Advocacy Guide: HIV/AIDS Prevention among IDUs
Author /
Institution
World Health Organization, United Nations Joint Programme on 
HIV/AIDS and United Nations Office on Drug and Crime, 2006
Description
This guide provides a systematic approach to advocating for
HIV/AIDS prevention among IDUs, outlines the principles advocacy
for HIV/AIDS prevention and care for IDUs, provides a step-by-step 
guide for establishing advocacy groups, description of tools and 
methods for achieving advocacy goals, and discusses the most used
arguments for advocacy.
Link to Tool http://www.who.int/hiv/pub/advocacy/idu/en/
Source /
Contact
Marketing and Dissemination World Health Organization 
20, Avenue Appia,1211 Geneva 27, Switzerland 
Tel: +41 22 791 2476; Fax: +41 22 731 4857
Email: bookorders@who.int
Web site: http://www.who.int/
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APPENDIX 2: ADDITIONAL WEB RESOURCES
General Health/HIV/AIDS
 
Centers for Disease Control and Prevention (CDC)
 
The CDC promotes health and quality of life by preventing and controlling disease, injury,
and disability.
www.cdc.gov/
The Joint United Nations Programme on HIV/AIDS (UNAIDS)
UNAIDS brings together the efforts and resources of 10 UN system organizations to the 
global AIDS response. Co-sponsors include UNHCR, UNICEF, WFP, UNDP, UNFPA,
UNODC, ILO, UNESCO, WHO, and the World Bank. Based in Geneva, the UNAIDS
secretariat works on the ground in more than 75 countries worldwide.
www.unaids.org
World Health Organization (WHO)
WHO is the directing and coordinating authority for health within the United Nations
system. It is responsible for providing leadership on global health matters, shaping the
health research agenda, setting norms and standards, articulating evidence-based policy 
options, providing technical support to countries, and monitoring and assessing health 
trends.
http://www.who.in/
General Drug Use
The International Drug Policy Consortium (IDPC)
The IDPC is a global network of 24 national and international NGOs (including IHRA) that
specialize in issues related to illegal drug use. The Consortium aims to promote objective 
and open debate on the effectiveness, direction, and content of drug policies at the 
national and international level and supports evidence-based policies that are effective in 
reducing drug-related harm. It disseminates the reports of its member organizations about
particular drug-related matters as well as offers expert consultancy services to
policymakers and officials around the world.
www.idpc.info
National Institute on Drug Abuse (NIDA)
NIDA provides strategic support and conduct of research across a broad range of
disciplines and ensures the rapid and effective dissemination and use of the results of that
research to significantly improve prevention, treatment, and policy as it relates to drug
abuse and addiction.
http://www.nida.nih.gov/
Substance Abuse & Mental Health Services Administration (SAMHSA)
SAMHSA funds and administers a portfolio of grant programs and contracts that support
state and community efforts to expand and enhance prevention and early intervention 
programs and to improve the quality, availability, and range of substance abuse treatment,
mental health, and recovery support services in local communities.
http://www.samhsa.gov/
United Nations Office on Drugs and Crime (UNODC)
The UNODC is mandated to assist Member States in their efforts to tackle illicit drugs,
crime, and terrorism. Their work program includes research and analytical work to
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increase the knowledge and understanding of drugs and crime issues and expand the 
evidence-base for policy and operational decisions.
http://www.unodc.org
General HIV & Drug Use

Centre for Research on Drugs and Health Behaviour (CRDHB)
 
The CRDHB recently moved from Imperial College London to the London School of
Hygiene and Tropical Medicine. It was founded in 1990 by Professor Gerry V. Stimson
(the current IHRA Executive Director) and is an international leader in multi-disciplinary
and intervention-based research on the social, behavioral, and epidemiological aspects of
drug use and health behavior.
www.lshtm.ac.uk/crdhb
Open Society Institute and Soros Foundation Network (OSI)
The Open Society Institute (OSI) is a private operating and grant-making foundation that
aims to shape public policy to promote democratic governance, human rights, and 
economic, legal, and social reform, and implements a range of initiatives to support the 
rules of law, education, public health, and independent media.
http://www.soros.org/
Risk Reduction
These Web sites provide regional and national networks for risk reduction practices, policies, and 
research.
Asian Harm Reduction Network
www.ahrn.net
Caribbean Harm Reduction Coalition
www.caribbeanharmreductioncoalition.htmlplanet.com/
Canadian Harm Reduction Network (CHRN)
www.canadianharmreduction.com
Correlation – European Network for Social Inclusion and Health
www.correlation-net.org
Eurasian Harm Reduction Network
www.harm-reduction.org
Harm Reduction Coalition (HRC) (USA)
www.harmreduction.org
International Harm Reduction Association
http://www.ihra.net/
Middle East and North African Harm Reduction Network (Mehahra)
www.menahra.org/
Latin American Harm Reduction Network (RELARD)
www.relard.org/
The International Network of People who Use Drugs (INPUD)
www.inpud.net
The International Youth Network for Harm Reduction (Youth RISE)
http://projects.takingitglobal.org/harmreduction
UK Harm Reduction Alliance (UKHRA)
www.ukhra.org
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Behavioral Interventions 

Diffusion of Effective Behavioral Interventions (DEBI)
 
The Diffusion of Effective Behavioral Interventions project (DEBI) is a U.S.-level strategy
to provide high-quality training and on-going technical assistance on selected, evidence-
based HIV/STD/Viral Hepatitis prevention interventions to state and community HIV/STD
program staff.
http://www.effectiveinterventions.org/
Equipment Access
Exchange Supplies
Exchange Supplies is a social enterprise that is firmly committed to developing and
supplying effective equipment and resources to improve and prolong the lives of drug 
users by reducing drug-related harm. They formed in 2001 as a way to take the initiative 
and produce citric acid sachets for needle exchanges to supply to drug users in the U.K.
www.exchangesupplies.org
Drug Abuse, Dependence, and Addiction Treatment

American Association for the Treatment of Opioid Dependence (AATOD)
 
The AATOD was founded in 1984 to enhance the quality of patient care in treatment
programs by promoting the growth and development of comprehensive methadone 
treatment services throughout the United States.
http://www.aatod.org/
Byrne Surgery, Redfearn
The Byrne Surgery is a medical practice which is committed to improving the outlook for
drug/alcohol users and their families by using a variety of treatments. The Web site is
dedicated to dependency treatments, research, and education. It contains summaries of
research articles, lectures, conferences, and links to other related information.
www.redfernclinic.com
Prisons
Canadian HIV/AIDS Legal Network
The Canadian HIV/AIDS Legal Network works with legal and human rights issues
related to HIV/AIDS. They aim to promote human rights of people living with, and
vulnerable to, HIV/AIDS, including prisoners. This includes access to HIV prevention,
treatment, and support services.
www.aidslaw.ca/prisons
International Centre for Prison Studies
The International Centre for Prison Studies seeks to assist governments and other
relevant agencies in developing appropriate policies on prisons and the use of
imprisonment.
http://www.prisonstudies.org/
International Corrections and Prison Association
The International Corrections and Prison Association aims to contribute to public safety
and healthier communities by encouraging and enabling best correctional practices in 
prisons and outside communities.
http://www.icpa.ca/
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